Europe

Sessions

PDF version
Wednesday, 23 October

09:00

e-poster session day 1

to
Digital kiosks
e-poster session

10:50

Advances in drug treatment

to
Auditorium II
Oral presentation session

Advancing addiction research: global perspectives and collaborative initiatives

to
Auditorium VI
Oral presentation session

Lives at risk: mental health and substance use

to
Auditorium VII
Oral presentation session

Prevalence of opioids and related harms

to
Auditorium VIII
Oral presentation session

Gambling: work-related, financial, and criminological issues

to
Room 5B
Oral presentation session

Building addiction workforce capacity

to
Room 5C
Oral presentation session

Support for recovery

to
Room 1.07
Short communication session
Closed session

ECR Programme — Scientific writing

to
Room 1.10
Workshop

Evaluation of drug consumption rooms: guidance step by step

to
Room 1.15
Workshop

13:20

Neuroscience and cognition

to
Auditorium III
Short communication session

Legal shifts and their Impact on drug use and sentencing

to
Auditorium IV
Oral presentation session

Drug policy and the criminal legal system

to
Auditorium VI
Oral presentation session

Gender and substance use

to
Auditorium VIII
Oral presentation session

Substance use interventions in youth

to
Room 5A
Oral presentation session

Meetings the needs of women who use drugs or alcohol

to
Room 1.06
Short communication session

Methods and measurement

to
Room 1.08
Short communication session

15:00

Challenges in community-based prevention

to
Auditorium I
Major session

The recovery journey

to
Auditorium III
Oral presentation session

Infectious diseases in people who inject drugs

to
Auditorium IV
Oral presentation session

Measuring drug market phenomenon

to
Auditorium VI
Oral presentation session

Substance use and psychosis

to
Auditorium VII
Oral presentation session

Surveillance of drug-related morbidity and mortality

to
Room 5A
Oral presentation session

Inequalities and needs of migrant groups

to
Room 5C
Oral presentation session

Responses to behavioural addictions

to
Room 1.05
Short communication session

Problematic gambling and gaming

to
Room 1.07
Short communication session

Conceptualising health and harms

to
Room 1.08
Short communication session

16:50

NPS: trends, concerns and response strategies

to
Auditorium III
Oral presentation session

Drug use trends

to
Auditorium IV
Oral presentation session

Understanding interrelationships: mental health and substance use

to
Auditorium VII
Oral presentation session

Psychedelics 1

to
Auditorium VIII
Oral presentation session

Opioid treatment 1

to
Room 5B
Oral presentation session

Motivations for use

to
Room 5C
Oral presentation session

Hepatitis C, HIV, and other drug related harms

to
Room 1.05
Short communication session

Opioids: trends, use and treatments

to
Room 1.06
Short communication session

18:30

Why are we not doing better at reducing drug-related deaths?

to
Auditorium I
Big debate
Thursday, 24 October

09:00

Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.

to
Room 1.10
Workshop

Workshop on conducting drug research in prison: Challenges and key recommendations from the European experience

to
Room 1.15
Workshop

10:50

Opioid treatment 2

to
Auditorium III
Oral presentation session

Opioid Agonist Treatment: novel formulations and challenges

to
Auditorium IV
Oral presentation session

Evidence informed drug and alcohol policy

to
Auditorium VI
Oral presentation session

Emerging drug harms, DCRs and other responses

to
Auditorium VII
Short communication session

Innovative methods for understanding drug markets and policy

to
Room 5A
Oral presentation session

Workers reaching marginalised groups

to
Room 5C
Oral presentation session

Challenges, threats, and opportunities in addiction publishing today

to
Room 1.05
Oral presentation session

EU research funding opportunities

to
Room 1.07
Workshop

Contemporary issues

to
Room 1.08
Oral presentation session

13:20

Novel neurobiology - cannabis, cognition and craving

to
Auditorium III
Oral presentation session

Understanding drug-related deaths

to
Auditorium IV
Oral presentation session

Young people, mental health and substance use

to
Auditorium VII
Oral presentation session

Pregnancy, drug use and care

to
Room 5B
Oral presentation session

Co-creating robust systems with workers

to
Room 5C
Oral presentation session

Understanding harm reduction: economic, social, and health perspectives

to
Room 1.05
Short communication session

European prevention curriculum: increasing the use of evidence-based prevention

to
Room 1.06
Short communication session

Women's realities of drug use

to
Room 1.08
Oral presentation session

Scenarios for the future of addictions fields by 2040

to
Room 1.10
Workshop

Writing for 'addiction' journals for early career researchers with DEPP Editors-in-Chief

to
Room 1.15
Workshop

15:00

NPS: Pharmacological Characterization and Substance Analysis

to
Auditorium III
Oral presentation session

Cannabis legalisation — models and impacts

to
Auditorium VI
Oral presentation session

Protective and risk factors in drug prevention

to
Room 5A
Oral presentation session

Policy issues in gambling

to
Room 5B
Oral presentation session

City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction

to
Room 1.07
Workshop

How to respond to real-time drug alerts in European countries ?

to
Room 1.15
Workshop

16:50

Mixed methods for understanding drug use

to
Auditorium III
Oral presentation session

Viral hepatitis among people who inject drugs

to
Auditorium IV
Oral presentation session

Substance use and mental health in treatment settings

to
Auditorium VII
Oral presentation session

Misuse of medicines

to
Auditorium VIII
Oral presentation session

From old to new: changes in drug use

to
Room 5C
Oral presentation session

Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform

to
Room 1.06
Short communication session

Internet, smartphones and social media use

to
Room 1.07
Short communication session
Friday, 25 October

09:00

A comparative discussion on the role, challenges, and opportunities for addiction nurses within Europe

to
Room 1.15
Workshop

10:50

The ripple effect: International developments in the opioid market and their potential implications for European public health and security

to
Auditorium I
Major session

Gaming and social media use

to
Auditorium III
Oral presentation session

Intentional and non-intentional drug-related deaths

to
Auditorium IV
Oral presentation session

Psychedelics 2

to
Auditorium VI
Oral presentation session

Unravelling the nexus: understanding drug-related violence across Europe

to
Auditorium VIII
Oral presentation session

Online monitoring

to
Room 5B
Oral presentation session

Substance use and treatment needs across European prisons

to
Room 5C
Oral presentation session

Emerging challenges in drug markets: monitoring, measurement & impacts

to
Room 1.05
Short communication session

Gaming and health

to
Room 1.06
Short communication session

Support for the addiction workforce

to
Room 1.07
Oral presentation session

How can cannabis policy goals inform the development of evaluation indicators?

to
Room 1.08
Workshop

13:20

Alcohol and other drug policies in the work setting – a perspective on European developments

to
Auditorium II
Oral presentation session

Overdose prevention

to
Auditorium IV
Oral presentation session

Addressing diverse treatment needs

to
Auditorium VI
Oral presentation session

Substance use and mental health in prison settings

to
Auditorium VII
Oral presentation session

Regulating cannabis supply policies in Europe: navigating the long road to change

to
Auditorium VIII
Oral presentation session

Prevention and addiction in underrepresented groups

to
Room 5A
Oral presentation session

Impact of drug policy on drug production & markets

to
Room 5B
Oral presentation session

Future of opioid markets in Europe: Foresight approaches

to
Room 1.10
Workshop

Presentations

Wed 23 Oct

09:00

e-poster

"How generational transmissions can shape life?" Evaluation of a genogram group therapy for people with ACoA syndrome

09:00 to 18:20
Digital kiosks
Katarzyna Iwanicka

e-poster

"Make the difference" - Qualifying professionals working with families with addiction issues

09:00 to 18:20
Digital kiosks
Rebekka Kleinat

e-poster

"Pictures (and Drugs) at an exibition"

09:00 to 18:20
Digital kiosks
Patrizio Lamonaca

e-poster

"Supersavers" manages large proportion of opioid overdoses – 5-year follow-up of a regional naloxone program, Sweden

09:00 to 18:20
Digital kiosks
Katja Troberg

e-poster

30 years of New Psychoactive Substances (NPS) in Europe. A first integrated public health assessment.

09:00 to 18:20
Digital kiosks
Julian Vicente

e-poster

A business of supplying harm reduction : a necessary evil?

09:00 to 18:20
Digital kiosks
François Destombe

e-poster

A digital approach to peer led recovery and social connection to address substance use/and or mental health challenges

09:00 to 18:20
Digital kiosks
Susan Barnes

e-poster

A feasibility and tolerability study of home-use tDCS in patients with substance use disorders (SUD)

09:00 to 18:20
Digital kiosks
Laia Miquel

e-poster

A Look at Non-Compliance: Examining Alcohol Industry Marketing Practices in Portugal

09:00 to 18:20
Digital kiosks
Hilson Cunha Filho

e-poster

A narrative review of nurse-led addiction models of care; informing the foundations for international nursing.

09:00 to 18:20
Digital kiosks
Sadie Lavelle Cafferkey

e-poster

A National Survey of Alcohol Care Teams (ACTs) in England: Characteristics of Patients and Components of Care

09:00 to 18:20
Digital kiosks
Philippa Case

e-poster

A Prospective Study: Patterns and Trends in Opioid Use and Treatment with Focus on Older Populations

09:00 to 18:20
Digital kiosks
Jo-Hanna Ivers

e-poster

A systematic review of second-hand smoking mass media campaigns (2002-2022)

09:00 to 18:20
Digital kiosks
Carmen Lim

e-poster

Activities and Experiences of Czech Adolescents in Cyberspace

09:00 to 18:20
Digital kiosks
Martin Dolejš

e-poster

Acute and Chronic Effects of Cannabis on the Neural Correlates of Working Memory in Adolescents versus Adults

09:00 to 18:20
Digital kiosks
Sorcha Hamilton

e-poster

Addiction, a volitional disorder.

09:00 to 18:20
Digital kiosks
Nicolas Figueired

e-poster

Addiction-related dreams: Interpretative Phenomenological Analysis of content and recovery from addiction

09:00 to 18:20
Digital kiosks
Shawn Rutledge

e-poster

Addictive Behaviours Workforce development: from global to European higher education programs

09:00 to 18:20
Digital kiosks
Olatz López Fernández

e-poster

ADDIRIS - Addiction and Harm Reduction: a global French-speaking network for online learning

09:00 to 18:20
Digital kiosks
Romain Bach

e-poster

Adherence to Opioid Use Disorder treatment with an extended-release weekly and monthly injectable buprenorphine

09:00 to 18:20
Digital kiosks
Michael Frost

e-poster

Advancing Addiction Interventions: Porto's Comprehensive Approach in the Municipal Health Plan

09:00 to 18:20
Digital kiosks
Paula Pinto Oliveira

e-poster

Adverse childhood experiences, adult attachment and parenting styles in a population with addictive behaviors

09:00 to 18:20
Digital kiosks
Teodomiro Pires

e-poster

Ageing in the context of the Opioid Maintenance Treatment in Portugal: Impact of public health policies on ageing users

09:00 to 18:20
Digital kiosks
Lara Queiroz Sampaio

e-poster

Alcohol use across trials of psychological interventions for bipolar: A systematic review and meta-analysis

09:00 to 18:20
Digital kiosks
Lauren Halsall

e-poster

Alcohol, Driving and Crime - Health Care and Justice: An Outreach Intervention

09:00 to 18:20
Digital kiosks
Celestino Cunha

e-poster

Alcohol, transitions and communities of belonging within marginalised groups – towards a model of understanding.

09:00 to 18:20
Digital kiosks
Peter Nelson

e-poster

An audit of patient’s Health / Social Care needs referred to a Dual Diagnosis Social Care pathway in Ireland

09:00 to 18:20
Digital kiosks
Aidan Cooney

e-poster

An evaluation of “harm reduction” outreach service evaluative research in Macau

09:00 to 18:20
Digital kiosks
Augusto Nogueira

e-poster

Anabolic steroid use and use of other image- and performance-enhancing drugs on the rise – A new substance use disorder

09:00 to 18:20
Digital kiosks
Raphael Magnolini

e-poster

Analysis of the satisfaction survey results of users of the Mobile Drug Consumption Room Program in Lisbon

09:00 to 18:20
Digital kiosks
Adriana Almeida

e-poster

Anxiety, Depression, Stress, and Self-Harm in relation to Gaming Disorder: A Longitudinal Study of Czech Adolescents

09:00 to 18:20
Digital kiosks
Jaroslava Suchá

e-poster

Applied health research in alcohol-related liver disease: a rapid qualitative inquiry with healthcare providers

09:00 to 18:20
Digital kiosks
Sofia Hemrage

e-poster

Applying foresight research for drug policy: Lessons from the DRUG-PREP project

09:00 to 18:20
Digital kiosks
Bert Hauspie

e-poster

Are Patients with Schizophrenia Reliably Reporting their Cannabis Use? An African Cross-sectional Study

09:00 to 18:20
Digital kiosks
Said Boujraf

e-poster

Assessing Food Security and Hunger in Heroin-Assisted Treatment (HAT) Participants: Insights from Norway's HAT Project

09:00 to 18:20
Digital kiosks
Omid Dadras

e-poster

Assessing hindering and facilitating factors of help-seeking behaviour in cannabis use: descriptive qualitative study

09:00 to 18:20
Digital kiosks
Laura Väätäinen

e-poster

Assessing progress towards viral hepatitis B and C elimination in prison settings in the European region

09:00 to 18:20
Digital kiosks
Riccardo Pisetta

e-poster

Assessing the prevalence of problem gambling among the Slovenian population

09:00 to 18:20
Digital kiosks
Špela Selak

e-poster

Assessing Therapeutic Alliance: A Pilot Study Measuring Therapeutic Alliance and It's Impact on Patient Outcomes

09:00 to 18:20
Digital kiosks
Siobhan Morse

e-poster

Association between slot machine gambling and debt recovery process-Finnish population-based study with register linkage

09:00 to 18:20
Digital kiosks
Tiina Latvala

e-poster

Balancing between care and control - staff perception on the introduction of new medication for opioid agonist treatment

09:00 to 18:20
Digital kiosks
Andrea Johansson Capusan

e-poster

Barriers to Substance Use Treatment as Perceived by Professionals and Arabic Refugees in Germany

09:00 to 18:20
Digital kiosks
Ebtesam Saleh

e-poster

Benefits of a Yoga intervention in portuguese female inmates: preliminary results

09:00 to 18:20
Digital kiosks
Andreia Nisa

e-poster

Building Capacity for Social Return on Investment Analysis of Supervised Consumption Services in Saskatoon SK, Canada

09:00 to 18:20
Digital kiosks
Barbara Fornssler

e-poster

Buprenorphine prescription patterns at a tertiary care hospital in northern India: A retrospective chart review

09:00 to 18:20
Digital kiosks
Abhishek Gupta

e-poster

Burden of disease due to drug use disorders in the European Union: analysis of 1990-2019 trends and patterns

09:00 to 18:20
Digital kiosks
Vera Pinheiro

e-poster

Burnout and Engagement in Addictive Behaviors and Dependencies HCWs at Portuguese North Region: an epidemiological study

09:00 to 18:20
Digital kiosks
Cátia Coutinho

e-poster

Can we prevent the misuse of prescription stimulants? : a case report

09:00 to 18:20
Digital kiosks
Ivana Todorić Laidlaw

e-poster

Cannabis use and its link to psychopathological and functional outcomes: Insights from self-reports and hair data

09:00 to 18:20
Digital kiosks
Lydia Johnson-Ferguson

e-poster

Cannabis use and severity of cannabis dependence among Georgian small-scale cannabis growers in 2021

09:00 to 18:20
Digital kiosks
Tamari Mgebrishvili

e-poster

Cannabis use and withdrawal and escalation to psychiatric intensive care

09:00 to 18:20
Digital kiosks
Edward Chesney

e-poster

Caring with Care: VITAE’s integrative and therapeutic model towards socially vulnerable individuals

09:00 to 18:20
Digital kiosks
Brenda Sousa da Silva

e-poster

Case Series: Prospective Study on the Efficacy of Pregabalin in Managing Opioid Withdrawal Syndrome

09:00 to 18:20
Digital kiosks
Sofia Golbreich

e-poster

Catalysts for Change: Youth-Driven Insights in Opioid Harm Reduction

09:00 to 18:20
Digital kiosks
Rebeca Calzada

e-poster

Challenges and needs of Cologne's open drug scene: insights from a quantitative study on Neumarkt square

09:00 to 18:20
Digital kiosks
Daniel Deimel

e-poster

Challenges in the management of skin and soft tissue infections among people who inject drugs in Athens, Greece.

09:00 to 18:20
Digital kiosks
Apostolia Fragkouli

e-poster

Changes in self-reported alcohol use post absolute alcohol sales bans: the case of Botswana during COVID pandemic.

09:00 to 18:20
Digital kiosks
J. Maphisa Maphisa

e-poster

Characterising South Africa’s drug markets with people who sell heroin, methamphetamine and cocaine

09:00 to 18:20
Digital kiosks
MJ Stowe

e-poster

Chemsex: An Umbrella Review

09:00 to 18:20
Digital kiosks
Liam Johnstone

e-poster

Combination non-medical use of gabapentin and medications for opioid use disorder: A qualitative study

09:00 to 18:20
Digital kiosks
Mance Buttram

e-poster

Common mental disorders in prisoners with childhood trauma and substance use; the role of emotion regulation

09:00 to 18:20
Digital kiosks
Faridah Nakoma

e-poster

Community led networking and advocacy for the elimination of discrimination of women who use drugs in Europe

09:00 to 18:20
Digital kiosks
Ligia Parodi

e-poster

Comorbid bloodborne diseases among people with opioid use disorders on medication-assisted treatment in Tanzania.

09:00 to 18:20
Digital kiosks
Dorothy Mushi

e-poster

COMPARED RETENTION RATES BETWEEN PATIENTS TREATED WITH BUVIDAL IN FRANCE vs. SUBLINGUAL BUPRENORPHINE (OPALE-2 STUDY)

09:00 to 18:20
Digital kiosks
Alice Deschenau

e-poster

Comparison of HOMA-IR, Tg/Glucose Index and Tg/HDL-C ratio for predicating MetSy in HCV seronegative heroin dependents

09:00 to 18:20
Digital kiosks
Zanina Perevska

e-poster

Complicated Alcohol Withdrawal Syndrome: retrospective study of an inpatient alcohol treatment unit

09:00 to 18:20
Digital kiosks
Ines Pereira

e-poster

ComunicAr’te - Communicating through Art in Group Therapy on Addictive Behaviors

09:00 to 18:20
Digital kiosks
Carla Matias

e-poster

Conceptual competence in addiction: integrative contributions from philosophical and theoretical work in psychiatry

09:00 to 18:20
Digital kiosks
Carl Erik Fisher

e-poster

Contribution of the workforce to retention of clients in Kombani Medically Assisted Therapy (MAT) in Kwale, Kenya.

09:00 to 18:20
Digital kiosks
Esther Mumo

e-poster

Cortical thickness and brain aging in individuals engaging in unhealthy alcohol use

09:00 to 18:20
Digital kiosks
Marco Hermesdorf

e-poster

COVID-19 and earthquakes-related stress, quality of life, mental health, and internet-based addictive behaviour

09:00 to 18:20
Digital kiosks
Tina Peraica

e-poster

Crack cocaine use, street life and migrant population. An Italian observatory by ItaRdd, Cnca, Forum Droghe.

09:00 to 18:20
Digital kiosks
Luca Censi

e-poster

Critical assessment of the role of compulsory treatment of drug use disorders in Germany

09:00 to 18:20
Digital kiosks
Ingo Ilja Michels

e-poster

DCR in Paris : a constant experiment

09:00 to 18:20
Digital kiosks
Victor Detrez

e-poster

Degree of smartphone addiction in the university environment

09:00 to 18:20
Digital kiosks
Raul Vernet

e-poster

Developing a Toolkit for health care professionals working with Pregnant People who use Drugs in Southern Africa

09:00 to 18:20
Digital kiosks
Julie-Anne Mac Donnell

e-poster

Developing practical tools for identifying and supporting treatment-relevant cognitive dys/functions

09:00 to 18:20
Digital kiosks
Maria Bravo Aguilera

e-poster

Development of complementary information to drug-related deaths statistics in Slovenia

09:00 to 18:20
Digital kiosks
Mateja Jandl

e-poster

Doping Prevention among Recreational Athletes and the Role of the Police

09:00 to 18:20
Digital kiosks
Tobias Elgán

e-poster

Drug checking via Syringe Vending Machines

09:00 to 18:20
Digital kiosks
Mariam Sherozia

e-poster

Drug-Facilitated Sexual Assaults involving GHB and GBL in Europe – recent evidence and a need for better monitoring.

09:00 to 18:20
Digital kiosks
María Flores López

e-poster

Drug-Related Deaths following Bariatric surgery: Case Series Report

09:00 to 18:20
Digital kiosks
Eman Mshari

e-poster

DUDIT-E Brazilian Adaptation and TrIE-AD Application Development: A Intervention Approach for Young Drug Users

09:00 to 18:20
Digital kiosks
Richard Alecsander Reichert

e-poster

Effectiveness of the brief intervention for methamphetamine users in Poland

09:00 to 18:20
Digital kiosks
Magdalena Rowicka

e-poster

Effects of a universal school based alcohol prevention intervention

09:00 to 18:20
Digital kiosks
Bert Hauspie

e-poster

Effects of oxytocin and nicotine addiction on psychosocial stress: an fMRI study

09:00 to 18:20
Digital kiosks
Jiecheng Ren

e-poster

Efficacy of a digital intervention to reduce or stop cannabis use : study protocol for a randomized controlled trial

09:00 to 18:20
Digital kiosks
Emmanuel Lahaie

e-poster

Electroencephalographic indices of stages of reward memory and implications for therapeutic memory reconsolidation

09:00 to 18:20
Digital kiosks
Shelan Ofori

e-poster

Electronic cigarettes use among secondary school students in Slovenia

09:00 to 18:20
Digital kiosks
Helena Koprivnikar

e-poster

Empowering higher education teachers using tripartite drug awareness training model to support youth well-being

09:00 to 18:20
Digital kiosks
Munir Sewani

e-poster

Enhanced Alcohol-Specific Pavlovian-to-Instrumental Transfer in Alcohol Use Disorder

09:00 to 18:20
Digital kiosks
Michael Smolka

e-poster

Enhancing HIV Self-Testing Uptake through Syringe Vending Machines: A Case Study in Tbilisi, Georgia

09:00 to 18:20
Digital kiosks
Irma Kirtadze

e-poster

Enrichment of Prevention Methodologies with Self Help/Mutual aid practices: The case of the Centre of Prevention Greece

09:00 to 18:20
Digital kiosks
Sotiris Lainas

e-poster

Estimation of prevalence (and patterns) of cannabis use from various data sources

09:00 to 18:20
Digital kiosks
Darja Lavtar

e-poster

Ethical considerations of responsible gambling in metaverse

09:00 to 18:20
Digital kiosks
Susanne Uusitalo

e-poster

Evaluation of a UK Bristol capillary blood service for blood-borne virus detection to reach HCV elimination targets

09:00 to 18:20
Digital kiosks
Stephanie Hutchings

e-poster

Evaluation of inpatient conversion from high dose methadone to long-acting injectable buprenorphine (LAIB)

09:00 to 18:20
Digital kiosks
Stuart Fisher

e-poster

Evaluation of participants' experiences enrolled in a community-based mobile withdrawal management service

09:00 to 18:20
Digital kiosks
Andrew Lodge

e-poster

Experiences of female substance users with trauma-sensitive yoga as complementary support in addiction treatment

09:00 to 18:20
Digital kiosks
Julie Schamp

e-poster

Experiences with Xylazine among Residential Treatment Patients

09:00 to 18:20
Digital kiosks
Courtney Nordeck

e-poster

Exploring Cultural Dynamics of Black Asian Ethnic Women in Addiction Recovery

09:00 to 18:20
Digital kiosks
Shinasa Shahid

e-poster

Exploring Diverse Applications of Multicriteria Decision Analysis in Drug Policy: A Comprehensive Overview.

09:00 to 18:20
Digital kiosks
Nicola Worcman

e-poster

Exploring dual diagnosis in opioid agonist treatment: A comparative study between the Czech Republic and Norway

09:00 to 18:20
Digital kiosks
Svetlana Skurtveit

e-poster

Exploring the gendered impact on women of the impact of the changes in commissioning in drug and alcohol services.

09:00 to 18:20
Digital kiosks
Victoria Beere

e-poster

Exploring the role of gender on treatment outcomes in older adults with alcohol use disorder

09:00 to 18:20
Digital kiosks
Jeppe Tryggedsson

e-poster

Features and correlates of Internet Gaming Disorder in women and men who play video games: a cross-national study

09:00 to 18:20
Digital kiosks
Caitlin McClure-Thomas

e-poster

Fentanyl among adolescent in Poland - the scale of the phenomenon and preventive actions

09:00 to 18:20
Digital kiosks
Ewelina Silecka-Marek

e-poster

Forgotten children - losses of children growing up with addicted parents

09:00 to 18:20
Digital kiosks
Szilvia Kassai

e-poster

Framing alcohol policies in non-prohibitionist States: An existentialist dilemma?

09:00 to 18:20
Digital kiosks
Subrata Biswas

e-poster

Frequency of cannabis and amphetamine use past month in patients on opioid maintenance treatment with buprenorphine

09:00 to 18:20
Digital kiosks
Natasha Simonovska

e-poster

From intrusive memory to craving in cocaine use disorder – An ecological momentary assessment study

09:00 to 18:20
Digital kiosks
Amelie Zacher

e-poster

Gender violence experienced by women who use drugs

09:00 to 18:20
Digital kiosks
Ana Isabel Ibar-Fañanás

e-poster

Generative AI to support Harm Reduction

09:00 to 18:20
Digital kiosks
Angus Bancroft

e-poster

Global trends and Challenges of the Drug Phenomenon in Central Asia

09:00 to 18:20
Digital kiosks
Ernest Robello

e-poster

Gratitude amidst unease: Interviews with Swedish forensic psychiatric male patients with substance use disorder

09:00 to 18:20
Digital kiosks
Charlotta Svensson

e-poster

Harm Reduction: A Pathway To Community Health in Nigeria

09:00 to 18:20
Digital kiosks
Fatima Abiola Popoola

e-poster

HCV screening in the treatment centers for people with addictions: lessons learned

09:00 to 18:20
Digital kiosks
Federica Mathis

e-poster

Hepatitis C and pharmaceutical multinationals. An approach to the case of Basque Country (Spain) in 2014/2015

09:00 to 18:20
Digital kiosks
Unai Perez de San Roman Landa

e-poster

High and repeated use of MDPV induce chronic psychosis in patients with no psychiatric history

09:00 to 18:20
Digital kiosks
Andrea Anastasi

e-poster

HIV among people who inject drugs in Stockholm - prevalence, incidence and treatment outcomes

09:00 to 18:20
Digital kiosks
Martin Kåberg

e-poster

Hospitalizations due to the use of psychoactive substances in Portugal: Impact assessment of the 2008 economic crisis

09:00 to 18:20
Digital kiosks
Joana Silva

e-poster

Hybrid skills transfer of the unplugged prevention programme in a French high school abroad (Lisbon, Portugal 2023 2024)

09:00 to 18:20
Digital kiosks
Marion Fal

e-poster

Identification and treatment of alcohol use disorder with the 15-method – implementation in psychiatric care

09:00 to 18:20
Digital kiosks
Jennie Sundbye

e-poster

If you don't know where you're going, why insist on running - A reflection on the lack of data on dropout...

09:00 to 18:20
Digital kiosks
Sofia Freitas

e-poster

Image and performance enhancing drugs among gym and fitness visitors in Slovenia – preliminary results

09:00 to 18:20
Digital kiosks
Julijana Zucchiati Godina

e-poster

Impact of Adherence to the Opioid Substitution Program on Social Determinants of Health in the West Zone of Porto

09:00 to 18:20
Digital kiosks
Isabel Ponte

e-poster

Impact of first cardiovascular event versus consecutive episodes on tobacco and alcohol use: a comprehensive analysis

09:00 to 18:20
Digital kiosks
Maria Teresa Pons

e-poster

Impact of fruit smoothie supplementation on psychological distress in patients undergoing opioid agonist therapy

09:00 to 18:20
Digital kiosks
Elaheh Javadi Arjmand

e-poster

Impact of the Decriminalization on Drug Use Experiences and Related Risks among People Who Use Drugs in British Columbia

09:00 to 18:20
Digital kiosks
Cayley Russell

e-poster

Implementation of a subject on the care of addiction in the Nursing degree: origin of the need and expectations.

09:00 to 18:20
Digital kiosks
Sheimah El Beijjaji Bouzbita

e-poster

Implementation of two transdiagnostic psychological interventions for alcohol use: Study protocol, preliminary results

09:00 to 18:20
Digital kiosks
Alba Abanades

e-poster

Improving the diagnosis and clinical outcomes on drug addict patients through quantitative spectrometer testing.

09:00 to 18:20
Digital kiosks
Teodora Ciolompea

e-poster

In search of protective factors against burnout in Addictive Behaviors and Dependencies HCWs at Portuguese North Region

09:00 to 18:20
Digital kiosks
Rui Tinoco

e-poster

IN VITRO INHIBITORY POTENTIAL OF CLASSIC HALLUCINOGENS LSD, 5-MEO-DMT AND MESCALINE OVER CYTOCHROME P450 ENZYMES

09:00 to 18:20
Digital kiosks
Mariana Carvalho

e-poster

Inpatient ketamine detoxification, characterization of a treatment-seeking population with complex needs

09:00 to 18:20
Digital kiosks
Osunwale Oni

e-poster

Integrating Seven Challenges Mastery Counselling and Trauma Informed Care in adolescent substance use interventions.

09:00 to 18:20
Digital kiosks
Daniel Mercieca

e-poster

Intervention methods for the psychological problems faced by the wives of individuals with substance use disorders.

09:00 to 18:20
Digital kiosks
Ranasinghe Mudiyanselage Sanjeewani Senevirathne

e-poster

Investigating the relationship between defense styles and treatment motivation of Turkish males with alcohol use problem

09:00 to 18:20
Digital kiosks
Fatmatüz Zehra Pehlivan

e-poster

Investigating the Relationship Between Stigma and Relapse in IDUs with HIV/AIDS in Pakistan

09:00 to 18:20
Digital kiosks
Jawwad Muhammad Shujaat

e-poster

Is addiction a brain-disease? An overview of the evidence

09:00 to 18:20
Digital kiosks
Chrysanthi Blithikioti

e-poster

Is Decriminalising drugs enough? Navigating alternatives to prohibitionism

09:00 to 18:20
Digital kiosks
Jorge Quintas

e-poster

Is Integrating Online Stop Smoking Support to Existing Online Talking Therapy Support Feasible?

09:00 to 18:20
Digital kiosks
Pamela Jacobsen

e-poster

Italian teenagers’ perceived exposure to Digital Alcohol Marketing

09:00 to 18:20
Digital kiosks
Franca Beccaria

e-poster

Italian Validation of Assessment of Recovery Capital Scale in Clinical Population with Alcohol and Drugs Use Disorder

09:00 to 18:20
Digital kiosks
Teo Vignoli

e-poster

Leveraging AI to supercharge the training and support of extended workforce in addiction services

09:00 to 18:20
Digital kiosks
Christina Todorova

e-poster

LGBTQIA2S+ perspectives on problem gambling among their peers: Preliminary results of semi-structured interviews

09:00 to 18:20
Digital kiosks
Anne-Marie Auger

e-poster

Life Entrapment or Trampoline? Understanding life experiences of rejected asylum seekers in Copenhagen’s open drug scene

09:00 to 18:20
Digital kiosks
Arash Setoodeh

e-poster

Lived/Living experiences: the potential for integrative collaborations

09:00 to 18:20
Digital kiosks
Mary Beth Zeni

e-poster

Long-term Effects of the STAD-model: A Multi-Component Responsible Beverage Service Intervention

09:00 to 18:20
Digital kiosks
Johanna Gripenberg

e-poster

Long-Term Outcomes of Substance Use Treatment: A 20-Year Follow-Up Study in the Swedish Addiction Treatment System

09:00 to 18:20
Digital kiosks
Tove Sohlberg

e-poster

Love Addiction: Trait Impulsivity, Emotional Dysregulation and Attachment Style

09:00 to 18:20
Digital kiosks
Jessica Dineen

e-poster

Making Hep C treatment more accessible for addictions patients in Belfast

09:00 to 18:20
Digital kiosks
Andrew Teeney

e-poster

Mania a Potu: Review of the literature

09:00 to 18:20
Digital kiosks
Ines Valada

e-poster

Mapping drug users’ spaces of fear in Cologne, Germany

09:00 to 18:20
Digital kiosks
Bo Tackenberg

e-poster

Mapping psychedelic retreats and other practices in the EU

09:00 to 18:20
Digital kiosks
Tereza Černíková

e-poster

Meaning and Self-control in Alcohol Use and Internalizing Symptoms: Causal Insights from (Non)clinical Populations

09:00 to 18:20
Digital kiosks
Marcel Näther

e-poster

Medicinal use of non-prescribed cannabis: motives for use, perceived effectiveness and barriers to treatment (MEDUSA)

09:00 to 18:20
Digital kiosks
Lisa Strada

e-poster

Mortality among long-term prescription opioid users

09:00 to 18:20
Digital kiosks
Gabriela Rolová

e-poster

Mortality Rates and cause-specific mortality in Patients with Substance-Induced Psychosis

09:00 to 18:20
Digital kiosks
Pihla Sassi

e-poster

Navigating cannabis access in zurich: A road safety perspective from early observations of the 'Züri Can' study

09:00 to 18:20
Digital kiosks
Patricia Dürler

e-poster

Negative affectivity, mania, and defense mechanisms in compulsive online buying-shopping disorder

09:00 to 18:20
Digital kiosks
Marina Cosenza

e-poster

Neurocognitive Impulsivity in Opiate Users at Different Lengths of Abstinence

09:00 to 18:20
Digital kiosks
Elena Psederska

e-poster

New criminal legal strategies towards a more effective inmate treatment (The KETHEA PROMITHEAS project)

09:00 to 18:20
Digital kiosks
Apostolos Tsirgoulas

e-poster

Nightlife recreational contexts in Viseu: sexism, sexual violence and potential associations with substance use

09:00 to 18:20
Digital kiosks
Inês Miguel Rodrigues Armelim

e-poster

No alcohol at night – Polish experiences

09:00 to 18:20
Digital kiosks
Marta Zin-Sedek

e-poster

Offspring of individuals with alcohol use disorders and professionals in addiction counseling: A qualitative study

09:00 to 18:20
Digital kiosks
Fran Calvo

e-poster

Oniomania: a case study according to the differential diagnosis

09:00 to 18:20
Digital kiosks
Sofia Nunes

e-poster

Oniomania: what is known today?

09:00 to 18:20
Digital kiosks
Margarida Duarte

e-poster

Online gambling and betting in India and their adverse psychological and social complications: A comprehensive review

09:00 to 18:20
Digital kiosks
Shyam Sundar Kanagarajan

e-poster

Online gambling and Loneliness: A State of Knowledge.

09:00 to 18:20
Digital kiosks
Volanirina Rasolofomamonjy

e-poster

Opiate-Dependent Service Users knowledge and attitudes towards Supervised Injecting Facilities

09:00 to 18:20
Digital kiosks
Annika Gibbons

e-poster

Optimizing Overdose Response in the Emergency Department: New challenges and initiatives in Scotland

09:00 to 18:20
Digital kiosks
Lisa Schölin

e-poster

OUTCAST REGISTRATION: an archive of imprisoned female drug users' biographies

09:00 to 18:20
Digital kiosks
Ulrike Möntmann

e-poster

Packaging of disposable vaping products and e-liquids in England, Canada, and the United States: a content analysis

09:00 to 18:20
Digital kiosks
Matilda Nottage

e-poster

People with mental disorders resulting in addiction to alcohol in Poland - legal aspects of medical, social assistance.

09:00 to 18:20
Digital kiosks
Joanna Rajewska de Mezer

e-poster

Personality traits and recovery

09:00 to 18:20
Digital kiosks
Elise Constance Fodstad

e-poster

Pilot implementation of a drug overdose reporting tool among Texas harm reduction organizations: A mixed methods study

09:00 to 18:20
Digital kiosks
Jake Samora

e-poster

Piloting a strategy to prevent and manage alcohol-related problems in underage population at risk in health services

09:00 to 18:20
Digital kiosks
Carla Filipa Bruguera

e-poster

Portuguese gym-goers versus Performance-enhancing Substances: What do we know?

09:00 to 18:20
Digital kiosks
Ana Sofia Tavares

e-poster

Post-prison support for First Nations men in Australia and Canada

09:00 to 18:20
Digital kiosks
Michael Doyle

e-poster

Prevalence of BBD among PWID in treatment settings in Palestine between 2019-2023

09:00 to 18:20
Digital kiosks
Abeer Habash

e-poster

Prevalence of substance use in Austrian prison systems

09:00 to 18:20
Digital kiosks
Andrea Gamper

e-poster

Prevention Matters: Towards a National Model of Prevention (within the National Programme on Illicit Drugs 2023 - 2030)

09:00 to 18:20
Digital kiosks
Mateja Markl

e-poster

Prevention of FASD in Luxembourg – a status report

09:00 to 18:20
Digital kiosks
Jonathan Uselding

e-poster

Problematic Mobile Phone Use Related Changes in Topological Organization of Functional Brain Networks

09:00 to 18:20
Digital kiosks
Lichang Yao

e-poster

Process indicators and outcomes of patients with SUD and Emotional Disorders: Comparison of pre-post COVID-19 pandemic

09:00 to 18:20
Digital kiosks
Oscar M. Lozano

e-poster

Professional satisfaction and discontent: perspectives of health professionals on Addictive Behaviors and Dependencies

09:00 to 18:20
Digital kiosks
Rita Valinho

e-poster

Program evaluation of a team-based approach addressing mental health and addictions in a Canadian urban centre

09:00 to 18:20
Digital kiosks
Andrew Lodge

e-poster

Providing psychiatric services for hepatitis C virus patients with substance use disorders

09:00 to 18:20
Digital kiosks
Anna Gorodetsky

e-poster

Psilocin inhibits CYP450 metabolism of isoforms 2A6 and 3A4

09:00 to 18:20
Digital kiosks
Andreia Machado Brito-da-Costa

e-poster

Psychological Phenotypes in Glambling Disorder: A case study using the Pathway Model

09:00 to 18:20
Digital kiosks
Ana Llorente

e-poster

Psychosocial and financial vulnerabilities in loot box purchasing: The mediating role of problem gambling

09:00 to 18:20
Digital kiosks
Anu Sirola

e-poster

Psychosocial Determinants of Cannabis Protective Behavioral Strategies: Perceived Efficacy and Social Norms

09:00 to 18:20
Digital kiosks
Fermin Fernández Calderón

e-poster

Psychosocial Factors Affecting Drug Relapse Among Youth in Pakistan

09:00 to 18:20
Digital kiosks
Abdul Waheed Tabish

e-poster

Public Health addressing illicit drug use and mental health disorders: Interinstitutional Community Intervention Group

09:00 to 18:20
Digital kiosks
Paula Pinto Oliveira

e-poster

Recreational Cannabis and Social Media Use: A Correlational Cross-Sectional Study

09:00 to 18:20
Digital kiosks
Roni Deli-Houssein

e-poster

Recreational substance use and cognition in a large cohort of young adults with hair testing: Something is not nothing

09:00 to 18:20
Digital kiosks
Lukas Eggenberger

e-poster

Reitox National Focal Point Drug Monitoring System as a Model for Monitoring Other Addictions in Czechia

09:00 to 18:20
Digital kiosks
Pavla Chomynova

e-poster

Resilience and Sense of Coherence as Mediators in the Association between Problematic Mobile Phone Use and Depression

09:00 to 18:20
Digital kiosks
Qi Dai

e-poster

Results of İntegrated Bio-Behavioral surveillance among PWID in Azerbaijan

09:00 to 18:20
Digital kiosks
Gunash Jafarova

e-poster

Rhabdomyolysis in patients following opioid overdose

09:00 to 18:20
Digital kiosks
Aleksandra Babulovska

e-poster

Riscos & Desafios Program: the students’ voice

09:00 to 18:20
Digital kiosks
Gizela Rendo

e-poster

Risk of relapse to non-opioids among patients treated with XR-NTX or BP-NLX: A randomized clinical trial

09:00 to 18:20
Digital kiosks
Arild Opheim

e-poster

Risks and challenges of scaling up the intervention – an analysis of the program dissemination process

09:00 to 18:20
Digital kiosks
Carla Rocha

e-poster

Risky online behavior in relation to social support, depression and anxiety in Czech adolescents

09:00 to 18:20
Digital kiosks
Terezie Babilonová

e-poster

Role of Psychiatric Nursing Staff in a Newly Founded Ward for Treatment of Adolescents Facing Addiction

09:00 to 18:20
Digital kiosks
Aleš Zajc

e-poster

SCHEMATIC FUNCTIONING AND EMOTIONAL REGULATION IN ALCOHOL DEPENDENCE: A CLINICAL AND NON-CLINICAL SAMPLE COMPARISON

09:00 to 18:20
Digital kiosks
Ana Catarina Nunes da Silva

e-poster

SCIRe: Substance Consumption Informative Research - testing hair in electronic music festivals

09:00 to 18:20
Digital kiosks
Ana Pego

e-poster

Scottish stakeholder views on closing the evidence to practice gap in substance use prevention

09:00 to 18:20
Digital kiosks
Tara Shivaji

e-poster

Self-inflicted cut throat injuries and substance use during COVID-19: An analysis from Nepal

09:00 to 18:20
Digital kiosks
Dipesh Bhattarai

e-poster

Self-rated health among patients in opioid agonist therapy

09:00 to 18:20
Digital kiosks
Jan Tore Daltveit

e-poster

Sleep dysregulation in alcohol use disorders. An exploratory study with a gender perspective.

09:00 to 18:20
Digital kiosks
Ana Llorente

e-poster

Smartphone addiction and sexual distress: preliminary findings of a study in Portugal

09:00 to 18:20
Digital kiosks
Pedro Campos

e-poster

Smoking among people who use drugs

09:00 to 18:20
Digital kiosks
Ingeborg Lund

e-poster

Social work diagnosis and intervention in a harm reduction service for People Who Use Drugs

09:00 to 18:20
Digital kiosks
Teresa Castro

e-poster

Spanish version of the Bergen Social Media Addiction Scale (BSMAS): validity, reliability and measurement invariance

09:00 to 18:20
Digital kiosks
Conchita Sisi Martin

e-poster

Stigma and substance use disorders: a scoping review of patient and health care professionals’ attitudes.

09:00 to 18:20
Digital kiosks
Ashlyn Schwartz

e-poster

Stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes

09:00 to 18:20
Digital kiosks
Theresa Caruana

e-poster

Substance Use Among College Students in India: Necessity for Intervention

09:00 to 18:20
Digital kiosks
Anju Dhawan

e-poster

Substance Use Treatment for non-speaker of the native language: Implications for migrants and the displaced

09:00 to 18:20
Digital kiosks
Mayar Nawara

e-poster

Suicidal Behaviors and Alcohol Dependence: A Comprehensive Literature Review

09:00 to 18:20
Digital kiosks
Marco Mota Oliveira

e-poster

Systematic analysis of Interventions for Opioid Use Disorder Among Adolescents

09:00 to 18:20
Digital kiosks
Joye Anestis

e-poster

Systematic review of recovery of neuropsychological function following abstinence in people with an Alcohol Use Disorder

09:00 to 18:20
Digital kiosks
Anna Powell

e-poster

Systemic biases: Attitudes of correctional staff toward incarcerated people receiving opioid agonist treatment

09:00 to 18:20
Digital kiosks
Joëlle Maguire-L

e-poster

Tell me who you are, I'll tell you what to do: designing specific interventions for different types of gamers

09:00 to 18:20
Digital kiosks
João Faria

e-poster

The addiction nursing workforce empowerment - from international perspective to the national implementation and bac

09:00 to 18:20
Digital kiosks
Vendula Pokorná

e-poster

The association between alexithymia and binge drinking among young people

09:00 to 18:20
Digital kiosks
Pelin Alpay

e-poster

The association between psychological distress and alcohol consumption and physical activity

09:00 to 18:20
Digital kiosks
Silvia Eiken Alpers

e-poster

The Autonomic Craving Signature: a biomarker of craving for personalized addiction treatment

09:00 to 18:20
Digital kiosks
Marc Auriacombe

e-poster

The comparison and analysis of blood antioxidant levels in alcohol and drug addiction

09:00 to 18:20
Digital kiosks
Nelly Sapojnikova

e-poster

The Development of an Alcohol Strategy for the Northwest Territories, Canada

09:00 to 18:20
Digital kiosks
Bryany Denning

e-poster

The effect of Cue-induced Retrieval and Reconsolidation with Episodic Foresight on craving in opioid users receiving MMT

09:00 to 18:20
Digital kiosks
Parnian Rafei

e-poster

The effect of smoking cessation interventions on socioeconomic inequalities in smoking: A Cochrane systematic review

09:00 to 18:20
Digital kiosks
Annika Theodoulou

e-poster

The effects of syringe service programs on overdose deaths in Tennessee

09:00 to 18:20
Digital kiosks
Ryan Edgerton

e-poster

The Impact of psychotherapy on Comorbid Borderline Personality Disorder and Substance Use Disorder: A Systematic Review

09:00 to 18:20
Digital kiosks
Manuel Jesús Ruiz Muñoz

e-poster

The impact of the tobacco law on hospitalizations due to the abusive consumption of psychoactive substances

09:00 to 18:20
Digital kiosks
Filipe Pinto

e-poster

The Intersection of Gambling with Smoking and Alcohol use in Great Britain: A Cross-Sectional Survey in October 2022

09:00 to 18:20
Digital kiosks
Loren Kock

e-poster

The Last Decade in Turkish Addiction Research: A Thesis-Based Analysis

09:00 to 18:20
Digital kiosks
Belgin Varol

e-poster

The lived experience of persons receiving harm reduction services, finding an oasis in the deserted life of drug use

09:00 to 18:20
Digital kiosks
Alexandros Tifas

e-poster

The Moral Improvisation of Harm Reduction in Abstinence Based Drug Policy Amongst Frontline Drug Workers in Hong Kong

09:00 to 18:20
Digital kiosks
Katie Lowe

e-poster

The necessary adaptation of a public Therapeutic Community to new needs of the treatment process.

09:00 to 18:20
Digital kiosks
Rita Fazenda Vieira

e-poster

The potential of eHealth in the treatment of substance use disorders: a perspcitive on digital theraies

09:00 to 18:20
Digital kiosks
André Almeida

e-poster

The prevalence of cannabis use disorders in people who use medicinal cannabis: a systematic review and meta-analysis

09:00 to 18:20
Digital kiosks
Danielle Dawson

e-poster

The prevalence of Mental Health Disorders Among Cannabis Users

09:00 to 18:20
Digital kiosks
Ada Hočevar Grom

e-poster

The prevalence, risk and protective factors of the co-morbidity of neurodiversity and substance use.

09:00 to 18:20
Digital kiosks
Catherine Comiskey

e-poster

The recovery of people with addictive behaviours and dependencies: intervention strategies of social workers

09:00 to 18:20
Digital kiosks
Sara Carvalho

e-poster

The role of cartoon humor in the context of addictology efforts for the prevention of alcohol and tobacco use

09:00 to 18:20
Digital kiosks
Linda Kočvarová

e-poster

The role of coping in the association between cannabis use disorder and mental health; a one-year prospective study

09:00 to 18:20
Digital kiosks
Nora de Bode

e-poster

The role of COVID-19 in sleep quality and cognitive performance in alcohol–dependent patients

09:00 to 18:20
Digital kiosks
Lea Kozina

e-poster

The role of dissociative experiences in the link between psychological distress and Problematic Social Network Sites Use

09:00 to 18:20
Digital kiosks
Simon Ghinassi

e-poster

The role of temperamental self-regulation in predicting treatment outcome in alcohol use disorders

09:00 to 18:20
Digital kiosks
Els Santens

e-poster

THE ROLE OF WORK IN THE TREATMENT OF INDIVIDUALS RECOVERING FROM ADDICTION

09:00 to 18:20
Digital kiosks
Farshad moshiri

e-poster

The Value of Outreach (VALOR): An evaluation of the implementation of alcohol assertive outreach in Greater Manchester

09:00 to 18:20
Digital kiosks
Nikolaos Mylonas

e-poster

Therapeutic Effects of Ayahuasca: The Psychological Processes Involved in the Relief of Depression and Grief.

09:00 to 18:20
Digital kiosks
Mafalda Pinto Ribeiro

e-poster

Therapy of alcohol-dependent women serving prison sentences in Polish prisons

09:00 to 18:20
Digital kiosks
Hanna Karaszewska

e-poster

Threat or opportunity: End-user perspectives on digital interventions for treatment of cannabis use

09:00 to 18:20
Digital kiosks
Jasmin Lostedt

e-poster

Training Program for Self-management of Substance Addiction Consequences – a Randomized Controlled Trial Pilot Study

09:00 to 18:20
Digital kiosks
Paulo Seabra

e-poster

Transgender and non-binary people's experiences with alcohol reduction in the UK: A cross-sectional study

09:00 to 18:20
Digital kiosks
Dean Connolly

e-poster

TREATMENT PROGRAMS FOR CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH MENTAL AND BEHAVIORAL DISORDERS DUE TO PAS USE

09:00 to 18:20
Digital kiosks
Andrej Kastelic

e-poster

Trilhos - Evaluation of a developmental prevention program

09:00 to 18:20
Digital kiosks
Inês Abraão

e-poster

Trust in healthcare providers for information about cannabis

09:00 to 18:20
Digital kiosks
Meredith Meacham

e-poster

Twenty years of integrated treatment of dual disorders in the netherlands: lessons learned

09:00 to 18:20
Digital kiosks
Anneke van Wamel

e-poster

Understanding Overdose Risk Perception in People who use Drugs - A Systematic Review

09:00 to 18:20
Digital kiosks
Kerry B.D. Campbell

e-poster

Unmasking addictions: exploring the role of attributional styles

09:00 to 18:20
Digital kiosks
Ana Tavares

e-poster

Use of CBD and low-THC products in North Macedonia

09:00 to 18:20
Digital kiosks
Sanja Prosheva

e-poster

Using a digital client segmentation tool among clients with problematic substance use

09:00 to 18:20
Digital kiosks
Ella Plaami

e-poster

Using Functional Near Infrared Spectroscopy to Detect Neurocognitive Differences Across Social Drinking Patterns

09:00 to 18:20
Digital kiosks
Rebecca Kuiper

e-poster

Veterinary Drugs as Toxic Adulterating Substances in the Street Drug Supply

09:00 to 18:20
Digital kiosks
Barry Logan

e-poster

Voices of the unhoused from Santa Fe, New Mexico: health status, substance use, and community harm reduction views

09:00 to 18:20
Digital kiosks
Laura Brown

e-poster

When substance use disorder and eating disorder intersect: an integrated care tool.

09:00 to 18:20
Digital kiosks
Zoya Barbier

e-poster

Willingness and Contextual Considerations for Supervised Consumption Sites among People Who Inject Drugs in Stockholm

09:00 to 18:20
Digital kiosks
Elin Holmén

e-poster

Workforce development and co production as key enablers of successful service delivery.

09:00 to 18:20
Digital kiosks
Martin Blakebrough

e-poster

Working memory in context: the role of alcohol distractors in low to heavy alcohol drinkers

09:00 to 18:20
Digital kiosks
Karis Colyer-Patel

e-poster

Working Towards Health and Wellness: The Infinite Pathways of Recovery

09:00 to 18:20
Digital kiosks
Meghann Perry

e-poster

“To smoke feels gender”: A Photovoice Study of Cannabis Use Among Transgender and Non-Binary Youth

09:00 to 18:20
Digital kiosks
Christian Barborini

10:50

Oral presentation

NIDA International Program Research Update

10:50 to 12:20
Auditorium VI
Tom Clarke

Oral presentation

Managing Benzodiazepine Dependence and High-Risk Use with Opiates: A feasibility study of a Co-produced Intervention

10:50 to 12:20
Auditorium II
Catriona Matheson

Oral presentation

Treatment of benzodiazepine withdrawal through taper dosing is most successful when it lasts less than 6 months.

10:50 to 12:20
Auditorium II
Alert Drishti

Oral presentation

Understanding the research capacity of Australian alcohol and other drug services

10:50 to 12:20
Auditorium VI
Robert Stirling

Oral presentation

Report from LX24 side event - Strengthening networks and sharing innovation in practices on research and surveillance in the drugs field

10:50 to 12:20
Auditorium VI
Vickna Kasinather
Charles Parry

Oral presentation

The effectiveness of naloxone in reversing opioid overdose: The European naloxone outcome research study (NalPORS)

10:50 to 12:20
Auditorium II
Nicola Metrebian

Short communication

A systematic review of the nuances of attachment, bonding and parenting for mothers in addiction recovery

10:50 to 12:20
Room 1.07
Louise McCulloch

Oral presentation

Addiction and financial burden: Longitudinal 6-time point analysis of risk factors for debt enforcement in Finland

10:50 to 12:20
Room 5B
Atte Oksanen

Oral presentation

Bipolar disorder and severe poisoning due to medicines or illicit substances

10:50 to 12:20
Auditorium VII
Aleksi Hamina

Short communication

Embodied Storytelling: An Accessible Approach to Re-storying in the Recovery Process

10:50 to 12:20
Room 1.07
Meghann Perry

Short communication

Emotional dysregulation as a predictor of cocaine severity and withdrawal symptoms

10:50 to 12:20
Room 1.07
Alba Palazón-Llecha

Oral presentation

Enhanced self-efficacy in HCV management: educating a multidisciplinary drug and alcohol workforce in Europe and Canada

10:50 to 12:20
Room 5C
Emma Day

Oral presentation

Exploring Australian addiction workers' views on inclusive treatment for transgender and gender diverse (TGD) clients.

10:50 to 12:20
Room 5C
Nic Robinson-Griffith

Short communication

Exploring Personal Strengths and Resources in Long-Term Substance Use Disorder Recovery: Insights from Lived Experience

10:50 to 12:20
Room 1.07
Myriam Beaulieu

Oral presentation

Foundations of Prevention Science and Practice Curriculum: Providing Technical Assistance through Training

10:50 to 12:20
Room 5C
Maria Paula Luna Jimenez

Oral presentation

Gambling Disorder and Work Disability: A National Registry Study in Sweden

10:50 to 12:20
Room 5B
Viktor Mansson

Oral presentation

Hazardous substance use and mental health among refugees in shared accommodations – a mixed-methods study

10:50 to 12:20
Auditorium VII
Miriam Lorenz

Oral presentation

Lisdexamfetamine in the treatment of methamphetamine dependence, a randomised controlled trial

10:50 to 12:20
Auditorium II
Nadine Ezard

Oral presentation

Modelling the wider socio-economic costs of problematic opioid use in the UK

10:50 to 12:20
Auditorium VIII
George Keel

Oral presentation

Prevalence of opioid dependence in Scotland, 2015-2020: results from a Multi Parameter Estimation of Prevalence model

10:50 to 12:20
Auditorium VIII
Hayley Jones

Oral presentation

Problem Gambling Among Criminal Sanction Clients: Project Overview

10:50 to 12:20
Room 5B
Sari Castrén

Short communication

Recovery does not stop at discharge: A qualitative evaluation of Alcohol Recovery Navigators in North East England.

10:50 to 12:20
Room 1.07
Emma-Joy Holland

Oral presentation

Scaling up Harm Reduction: Results of the 3-year Take-Home Naloxone project NALtrain in Germany.

10:50 to 12:20
Room 5C
Simon Fleißner

Oral presentation

Suicide-related service presentations following residential treatment for substance use disorders: a data linkage study

10:50 to 12:20
Auditorium VII
Calvert Tisdale

Short communication

The effect of Individual Placement and Support on employment outcomes for individuals with substance use disorders

10:50 to 12:20
Room 1.07
Eline Borger Rognli

Oral presentation

The impact of severe mental illness on treatment retention and all-cause mortality of people in opioid agonist treatment

10:50 to 12:20
Auditorium VII
Nicola Jones

Oral presentation

The reciprocal effects of gambling expenditure and crime.

10:50 to 12:20
Room 5B
Don Weatherburn

Short communication

The role of specialist substance use and addiction treatment in building recovery capital

10:50 to 12:20
Room 1.07
Florian De Meyer

Oral presentation

Twenty-one years of heroin-related mortality in Australia: Joinpoint regression analysis of trends by age and gender

10:50 to 12:20
Auditorium VIII
Amanda Roxburgh

Oral presentation

Underestimate of deaths due to specific opioids in England and Wales for a decade

10:50 to 12:20
Auditorium VIII
Shuoqi Chen

Short communication

Understanding the process of drug addiction recovery through learning from lived experience

10:50 to 12:20
Room 1.07
Thomas Martinelli

13:20

Oral presentation

Why is a gender perspective needed in the drug field? Insight from the latest European drugs data.

13:20 to 14:50
Auditorium VIII
Linda Montanari

Short communication

Alcohol prevention: a review using Topic Modelling

13:20 to 14:50
Room 1.08
Nina Harth

Short communication

Attention and reward related brain activity in cannabis users: A registered report of a longitudinal study

13:20 to 14:50
Auditorium III
Inês Macedo

Short communication

Barriers and Enablers in Disclosing Substance Use by Pregnant Women in Australian prisons

13:20 to 14:50
Room 1.06
So Bi Kim

Oral presentation

Bridging the Gap: Exploring School Survey Data in Drug Policy and Prevention - Insights from the ESPAD-MedSPAD Project

13:20 to 14:50
Room 5A
Elisa Benedetti

Short communication

Cannabis and mental health in Germany: a baseline estimation pre legalization

13:20 to 14:50
Room 1.08
Eva-Maria Krowartz

Short communication

Cognitive impairment as a predictor of long-term psychological distress in patients with polysubstance use disorders

13:20 to 14:50
Auditorium III
Jens Hetland

Oral presentation

Developing and operationalising a multi-component drug outreach service for young people aged 16-25 in England

13:20 to 14:50
Room 5A
Zoe Welch

Short communication

Digital Invisibility: Presence of Substance Use Disorder Treatment Programs for Women in the Caribbean

13:20 to 14:50
Room 1.06
Rocio Suarez Ordoñez

Short communication

Does lisdexamfetamine maintenance help or hinder cognitive function in people with current methamphetamine dependence?

13:20 to 14:50
Auditorium III
Raimondo Bruno

Oral presentation

Drug-induced homicide laws in the US: current trends, stakeholder opinions, and public health impacts

13:20 to 14:50
Auditorium VI
Jennifer Carroll

Short communication

Easy to reach, hard to research: cognitive function and substance use characteristics of people with severe drug use.

13:20 to 14:50
Auditorium III
Nina Auestad

Short communication

Evaluation of heroin-assisted treatment in Norway: Protocol for a mixed methods study

13:20 to 14:50
Room 1.08
Lars Henrik Myklebust

Oral presentation

Gender Compression Over Time in Measures of Cannabis Use by Age and Cohort in the United States

13:20 to 14:50
Auditorium VIII
Michael Vuolo

Oral presentation

Global coverage of interventions to prevent and manage injecting drug use related harms in prisons: a systematic review

13:20 to 14:50
Auditorium VI
Thomas Santo Jr.

Short communication

In favor or against the codependency concept: A narrative review of arguments in scientific literature

13:20 to 14:50
Room 1.08
Alexis Beaulieu-Thibodeau

Oral presentation

Judge Demographics and Their Impact on Sentencing of Drug Crimes

13:20 to 14:50
Auditorium IV
Sarah Henry Davis

Oral presentation

Leximetric analysis of drug laws and evaluation of outcomes: cross-country analyses approach

13:20 to 14:50
Auditorium IV
Carla Rossi

Oral presentation

MATPACT: An innovative approach to finding Scotland’s forgotten generation

13:20 to 14:50
Auditorium VI
Marion Gillies

Oral presentation

Navigating the Shift: Understanding the Dynamics of Cannabis Use in Germany Amidst Legalization Prospects

13:20 to 14:50
Auditorium IV
Sally Olderbak

Short communication

Neural Correlates of Addiction: A Resting-State Meta-Analysis of Substance Use Disorders and Behavioral Addictions

13:20 to 14:50
Auditorium III
Marc Ritter

Short communication

NK1 antagonism modulates negative emotional processing in abstinent opioid dependent individuals and healthy controls

13:20 to 14:50
Auditorium III
Lexi Hand

Short communication

Phosphatidylethanol as a screening tool for alcohol consumption during pregnancy

13:20 to 14:50
Room 1.06
Margareeta Häkkinen

Oral presentation

Policy and Practice Responses to Drug-Related Deaths: Governance issues in English and Welsh Prisons, 2015-2021

13:20 to 14:50
Auditorium VI
Karen Duke

Short communication

Prevalence and trends of ethanol and drugs among arrested drivers in Norway in the period 2013-2023

13:20 to 14:50
Room 1.08
Ragnhild Jamt

Oral presentation

Risk and protective factors in adolescents: adapting Communities that Care Youth Survey for Portuguese context

13:20 to 14:50
Room 5A
Susana Henriques

Oral presentation

Risk factors for the gambling, smoking and alcohol consumption triad: an observational study in Portuguese adolescents

13:20 to 14:50
Room 5A
Pedro Ramos

Oral presentation

Smoking and nicotine use behaviours among women of reproductive age: a ten-year population study in England

13:20 to 14:50
Auditorium VIII
Sharon Cox

Short communication

Social Cognition in people with substance use disorders

13:20 to 14:50
Auditorium III
Sónia Rodrigues

Short communication

The bodily parallel: Bridging Gaps in Current Theories of Addiction and Interoception

13:20 to 14:50
Auditorium III
Mateo Leganes-Fonteneau

Oral presentation

The effects of legislative measures for 3-MMC in the Netherlands on drug sample composition and self-reported effects.

13:20 to 14:50
Auditorium IV
Pieter Oomen

Short communication

The important role of social connectedness in the alcohol use of women aged 50 to 62 years.

13:20 to 14:50
Room 1.06
Grainne Clarke

Oral presentation

The perspective of transgender and non-binary people on their substance use trajectories and resilience processes

13:20 to 14:50
Auditorium VIII
Abdelhakim Missoum

Short communication

The relationship between cannabis and tobacco use - a systematic review and meta-analysis

13:20 to 14:50
Room 1.08
Tesfa Mekonen

Short communication

Tuning In for Chemistry: Setting up a multi-instrument mobile drug-checking lab at a 7-day psychedelic music festival

13:20 to 14:50
Room 1.08
Daniel Martins

Short communication

Utilization of pharmacological treatment for alcohol use disorder in pregnancy in the total Swedish population

13:20 to 14:50
Room 1.06
Sara Wallhed Finn

15:00

Oral presentation

Increased hepatitis C and HIV incidence among people who inject drugs in Montreal, Canada, 2011-2023

15:00 to 16:30
Auditorium IV
Sarah Larney

Keynote presentation

Evidence-based prevention through collaborative action? Opportunities and challenges for community-based participatory research in prevention science

15:00 to 16:30
Auditorium I
Samuel Tomczyk

Keynote presentation

Challenges in community-based prevention

15:00 to 16:30
Auditorium I
Harry Sumnall

Keynote presentation

The key components of CTC, including forming intersectoral coalitions, using a data-driven and needs-oriented approach to select evidence-based measures, and considering local contextual conditions during implementation.

15:00 to 16:30
Auditorium I
Maximilian von Heyden

Keynote presentation

What do we (not) know about community-based prevention and how to move forward?

15:00 to 16:30
Auditorium I
Ina Koning

Oral presentation

"Boxing Clever Cork saved my life": an evaluation of an Irish early addiction recovery initiative

15:00 to 16:30
Auditorium III
Rebekah Brennan

Short communication

A mindfulness-based intervention for craving reduction in gambling and video gaming disorder: A case study.

15:00 to 16:30
Room 1.05
Francisco José Rivero Ramón

Short communication

A pilot program using Tabletop Role-Playing Games to reduce social anxiety and addiction symptoms in online gamers

15:00 to 16:30
Room 1.05
Joël Billieux

Oral presentation

A Safer Downtown for All: Including People Who Use Drugs in the Solutions to Social Disorder

15:00 to 16:30
Auditorium III
Rob Boyd

Short communication

Accessibility, local socioeconomic disadvantage and expenditure on electronic gambling machines

15:00 to 16:30
Room 1.07
Jani Selin

Oral presentation

Acute drug-toxicity presentations involving crack cocaine to Euro-DEN Plus sentinel hospitals in Europe from 2014-2022

15:00 to 16:30
Room 5A
Isabelle Giraudon

Oral presentation

Antipsychotics and relapse risk in persons with first-episode psychosis and co-occurring cannabis use disorder

15:00 to 16:30
Auditorium VII
Heidi Taipale

Short communication

Associations between mental health and substance use in higher education students in Germany – a cross-sectional study

15:00 to 16:30
Room 1.08
Robert Hrynyschyn

Oral presentation

Associations of alcohol consumption with long-term mortality of ART-naïve persons seeking HIV care. 

15:00 to 16:30
Auditorium IV
Daniel Fuster

Short communication

Barriers and facilitators for accessing HCV care in PWID: a qualitative study using an intersectional approach

15:00 to 16:30
Room 1.08
Ilhame Anwar

Short communication

Barriers and facilitators to accessing drug treatment services for people who use drugs in Oman: a qualitative study.

15:00 to 16:30
Room 1.08

Oral presentation

Building Capacity For Future Evaluation of Residential Treatment for People Experiencing Homelessness and Addiction

15:00 to 16:30
Auditorium III
Ed Addison

Oral presentation

Cannabinoid Use Experience among inpatients with psychotic symptoms – A Cross-Sectional study in a Portuguese Hospital

15:00 to 16:30
Auditorium VII
Carolina Afonso Romano

Oral presentation

Challenges and support needs among persons with a migration background who use drugs in four metropolitan cities

15:00 to 16:30
Room 5C
Wouter Vanderplasschen

Oral presentation

Decentralized consultation for infectious diseases with at-risk populations: preliminary results

15:00 to 16:30
Auditorium IV
Paulo Caldeira

Oral presentation

Documenting major shifts in methamphetamine and heroin prices and purity in metropolitan and rural Victoria, Australia

15:00 to 16:30
Auditorium VI
Kasun Rathnayake

Oral presentation

Drug markets and financial flows: underground banking in the Netherlands

15:00 to 16:30
Auditorium VI
Nienke Liebregts

Oral presentation

Drug poisoning deaths of under 30-year-olds – Key issues in the cause of death investigation documents

15:00 to 16:30
Room 5A
Sanna Rönkä

Oral presentation

Drug use and (non-)use of addiction treatment by women in French Guyana: gender and migration effects

15:00 to 16:30
Room 5C
Estelle Filipe

Oral presentation

Effects of recreational cannabis versus black market: A randomized controlled trial in Switzerland (WEED CARE)

15:00 to 16:30
Auditorium VI
Lavinia Baltes

Short communication

Efficacy assessment of the universal problem-gambling prevention program "What at stake?"

15:00 to 16:30
Room 1.05
Daniel Lloret-Irles

Short communication

Envisioning youth-dedicated overdose prevention and drug consumption sites in Canada and Portugal

15:00 to 16:30
Room 1.08
Kali-olt Sedgemore

Short communication

Exploring the biopsychosocial needs of ageing heroin users in treatment in Malta: implications for service provision

15:00 to 16:30
Room 1.08
Anna Grech

Short communication

Extended hours of video game play and negative physical symptoms and pain

15:00 to 16:30
Room 1.07
Janni Leung

Short communication

Financial hardship and gambling severity: a population-based study in Finland

15:00 to 16:30
Room 1.07
Tanja Grönroos

Short communication

Harmful types of gambling: Changes and emerging trends in longitudinal helpline data

15:00 to 16:30
Room 1.07
Håkan Wall

Oral presentation

How do purity and price of cocaine affect consumption in Austria?

15:00 to 16:30
Auditorium VI
Birgit Priebe

Short communication

Late relapse among ex-smokers using e-cigarettes following a quit attempt: a prospective one-year follow-up study

15:00 to 16:30
Room 1.08
Lion Shahab

Short communication

Mental health in people with hazardous cannabis and alcohol use - insights from a study of regulated cannabis sales

15:00 to 16:30
Room 1.08
Maximilian Buschner

Oral presentation

Migrants in the criminal justice system: A qualitative understanding of the role of substance use in their lives

15:00 to 16:30
Room 5C
Marjolein De Pau

Oral presentation

Mortality among first-time opioid agonist therapy patients in Austria, 2002-2021: A national retrospective cohort study

15:00 to 16:30
Room 5A
Tanja Schwarz

Oral presentation

Mothers receiving substance use treatment involved in care proceedings: A record linkage cohort study

15:00 to 16:30
Room 5A
Martha Canfield

Short communication

Online Gambling Companies’ Interpretation of Duty of Care and its Implication for Responsibilisation of Gambling Related Harm

15:00 to 16:30
Room 1.07
Maria Persson

Oral presentation

Psychoactive Substance Use Among Russian Migrants Relocated to Georgia Following the 2022 Ukrainian Invasion

15:00 to 16:30
Room 5C
David Otiashvili

Oral presentation

Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis

15:00 to 16:30
Auditorium VII
Antti Mustonen

Oral presentation

Refugees & drug use in Belgium: A national study on drug-related intervention needs in the reception setting (DrugInt)

15:00 to 16:30
Room 5C
Charlotte de Kock

Short communication

Religiosity and gambling - moderating role of reflective thinking: A Polish-Georgian Study

15:00 to 16:30
Room 1.07
Rafał Bartczuk

Short communication

Substance induced psychosis among persons with concurrent mental health and substance use disorders under pandemic

15:00 to 16:30
Room 1.08
Jørgen G. Bramness

Short communication

Suicide by people in contact with drug and alcohol services: a national study 2021 to 2022

15:00 to 16:30
Room 1.08
Patrick Horgan

Oral presentation

Superiority and cost-effectiveness of Individual Placement and Support for people with alcohol and drug dependence

15:00 to 16:30
Auditorium III
John Marsden

Short communication

The influence of CBT based treatment and therapeutical contract guidelines on a problem gambler abstinence treatment

15:00 to 16:30
Room 1.05
Pedro Hubert

Short communication

The long and winding road to gambling disorder treatment

15:00 to 16:30
Room 1.05
David Hodgins

Short communication

The “Me and others” prevention program: impact evaluation in a sample of Portuguese adolescents

15:00 to 16:30
Room 1.05
Joana Alexandre

Short communication

Toward a classification of technology design features promoting potentially addictive online behaviors

15:00 to 16:30
Room 1.05
Maèva Flayelle

Short communication

What increases the risk of problem gambling in adolescents? Findings from the Greek arm of the ESPAD study

15:00 to 16:30
Room 1.07
Alexandra Primeti

Oral presentation

“Into a whirlwind”: Navigating psychosis and anti-psychotic treatment among youth entrenched in an urban drug scene

15:00 to 16:30
Auditorium VII
Trevor Goodyear

Oral presentation

“They kicked me out of hospital twice”: barriers and facilitators accessing care with an injecting-related infection

15:00 to 16:30
Auditorium IV
Samantha Colledge-Frisby

16:50

Oral presentation

20-year trends in Australian methamphetamine-related deaths: An age–period–cohort–interaction analysis

16:50 to 18:20
Auditorium IV
Oisin Stronach

Oral presentation

A Collaborative Approach to New Drug Identification in an Emerging Drug Early Warning System

16:50 to 18:20
Auditorium III
Donna Papsun

Oral presentation

Achieving universal health coverage of opioid agonist treatment in Norway: a cost-utility analysis

16:50 to 18:20
Room 5B
Prayash Chaudhary

Short communication

Adão e Eva II Project – HIV, Hepatitis and other STI’s prevention and screening among hard-to-reach populations

16:50 to 18:20
Room 1.05
Paulo Anjos

Oral presentation

AN IMPLEMENTATION SCIENCE EVALUATION OF SCOTLAND’S FIRST HEROIN ASSISTED TREATMENT (HAT) FACILITY

16:50 to 18:20
Room 5B
Andrew McAuley

Short communication

Are Australian pharmacists willing and prepared to offer Hepatitis C services? Findings from a representative sample

16:50 to 18:20
Room 1.05
Louisa Picco

Short communication

Being Seen and Heard: Exploring the Relational Dimension of Heroin Assisted Treatment in Norway.

16:50 to 18:20
Room 1.06
Vegard Haukland

Oral presentation

Codeine, oxycodone, and tramadol prescription prior to overdose deaths compared to toxicological findings

16:50 to 18:20
Auditorium IV
Hilde Edvardsen

Oral presentation

Comorbidity of substance use disorders and other mental health disorders: towards a common European approach

16:50 to 18:20
Auditorium VII
Marta Torrens

Short communication

Death after residential treatment for opioid use disorder among people using fentanyl

16:50 to 18:20
Room 1.06
Jan Gryczynski

Oral presentation

Effects of cannabis use timing and formulation on sleep among young adults who report high-intensity alcohol use

16:50 to 18:20
Auditorium VII
Elizabeth R. Aston

Oral presentation

Emergence of semi-synthetic cannabinoids in Europe – a perspective from the European Union Early Warning System

16:50 to 18:20
Auditorium III
Rachel Christie

Oral presentation

Examining Associations Between Alcohol and Cannabis Simultaneous and Concurrent Co-Use and Mental Health Outcomes

16:50 to 18:20
Auditorium VII
Bradley Conner

Short communication

Global utilization trends for weekly/monthly injectable buprenorphine (CAM2038) in the treatment of Opioid Use Disorder

16:50 to 18:20
Room 1.06
Michael Frost

Short communication

HCV antibody and RNA testing combined with nursing and peer-based outreach to enhance HCV testing and treatment among vulnerable groups

16:50 to 18:20
Room 1.05
Solange Mendes Ascensão

Oral presentation

Heavy drinking among ‘sober generation’ youth: a longitudinal study

16:50 to 18:20
Room 5C
Marit Edland-Gryt

Short communication

Improving the model of care pathway for HCV between the drug care centres and their referral hospitals in Catalonia.

16:50 to 18:20
Room 1.05
Elena Torrell -Pedreira

Short communication

Looking under rocks: Skin infections in people who use drugs: a mixed-methods investigation in Wales

16:50 to 18:20
Room 1.05
Michelle Hughes

Oral presentation

Medical use of psychedelic substances: EUDA's monitoring of key developments

16:50 to 18:20
Auditorium VIII
Alexander Söderholm

Oral presentation

Monitoring intravenous drugs use in Spain through syringe residue analysis

16:50 to 18:20
Auditorium IV
Carlos Pernas-Fraguela

Oral presentation

Motivations for cocaine use: relation with drug use patterns, risks and how this informs prevention

16:50 to 18:20
Room 5C
Eva Blomme

Oral presentation

Motivations underlying co-use of benzodiazepines and opioids in the UK: a qualitative study

16:50 to 18:20
Room 5C
Gaby Vojt

Short communication

Oxycodone and Morphine use in hospitals and primary healthcare in Norway 2010-2021

16:50 to 18:20
Room 1.06
Eirik Haarr

Short communication

Prevalence and microelimination of Hepatitic C in intravenous drug users - improving linkage to care

16:50 to 18:20
Room 1.05
Eva-Carina Heier

Oral presentation

Reduced health care utilization after entering opioid agonist treatment; change in mental and somatic health domains

16:50 to 18:20
Room 5B
Thomas Clausen

Oral presentation

Route-Dependent Subjective Effects of Medical Heroin in HAT: Implications for Treatment Trajectories

16:50 to 18:20
Room 5B
Silvana De Pirro

Oral presentation

Self-therapeutic use of psilocybin, MDMA and ketamine among Dutch nightlife attendees.

16:50 to 18:20
Auditorium VIII
Frederiek Schutten

Short communication

STTBI risk reduction with OAT among people with prescription-type opioid use disorder

16:50 to 18:20
Room 1.05
M. Eugenia Socias

Oral presentation

Synthetic cathinones in drug-related deaths – an alarming issue or triviality?

16:50 to 18:20
Auditorium III
Ilkka Ojanperä

Oral presentation

The relationship between self-reported childhood maltreatment and mental health in substance use disorders

16:50 to 18:20
Auditorium VII
Aleksander Hagen Erga

Oral presentation

The U.S. Psilocybin Landscape: Policy Evolution and Nationally Representative Insights

16:50 to 18:20
Auditorium VIII
Beau Kilmer

Oral presentation

Trends in GHB use and harms in Australia

16:50 to 18:20
Auditorium III
Rachel Sutherland

Short communication

Trends in the detection and co-detection of drugs in a population attending opioid agonist treatment: 2010 to 2020

16:50 to 18:20
Room 1.06
Gráinne Cousins

Oral presentation

What are the reasons for injecting methadone? A qualitative study among people who inject drugs in Barcelona

16:50 to 18:20
Auditorium IV
Gabriela Barbaglia

Oral presentation

‘Russian Roulette’: how do people who co-use benzodiazepines and opioids experience the absence of harm reduction?

16:50 to 18:20
Room 5C
Hannah Poulter

18:30

Discussion

Why are we not doing better at reducing drug-related deaths?

18:30 to 19:30
Auditorium I
Thomas Clausen
Marie Jauffret-Roustide
Keith Humphreys
Paul Dietze
Katri Abel-Ollo
Thu 24 Oct

10:50

Oral presentation

Long-acting injectable buprenorphine for opioid use disorder: key findings from a longitudinal qualitative study

10:50 to 12:20
Auditorium IV
Joanne Neale

e-short communication

Ensuring Quality Care: community-led monitoring of client satisfaction and accessibility of OAT programs

10:50 to 12:20
Auditorium IV
Maria Plotko

Oral presentation

Adapting Opioid Therapy: Transition from Methadone to Slow-Release Morphine Amid COVID-19 Supply Chain Disruptions

10:50 to 12:20
Auditorium IV
Artūras Barkus

Oral presentation

A Global Perspective on Treatment Service Provision for Opioid Use Disorders

10:50 to 12:20
Auditorium III
Arash Khojasteh Zonoozi

Oral presentation

A Holistic Multi-Disciplinary Healthcare Pathway for Older Men who use Anabolic Androgenic Steroids

10:50 to 12:20
Room 1.08
Evelyn Hearne

Short communication

A scoping review of mass media interventions intended to reduce stigma towards people who use drugs

10:50 to 12:20
Auditorium VII
Adam Holland

Oral presentation

A wastewater-based approach to monitor shifting trends in illicit drugs consumption in Switzerland

10:50 to 12:20
Room 5A
Livia Andrani

Oral presentation

Cannabis policy and practice in Finland: from social media discussions to citizens initiatives

10:50 to 12:20
Room 1.08
Aleksi Hupli

Discussion

Challenges, threats, and opportunities in addiction publishing today

10:50 to 12:20
Room 1.05
John Marsden
Matilda Hellman
Anees Bahji
Bryon Adinoff

Short communication

Changes in the use of non-prescribed hydromorphone and unregulated opioids use in Vancouver, Canada, 2018-2022

10:50 to 12:20
Auditorium VII
Kanna Hayashi

Oral presentation

Clinicians’ experience of providing heroin-assisted treatment: Key rewards and challenges

10:50 to 12:20
Room 5C
Rune Ellefsen

Short communication

Definition of public amenity in drug consumption room literature: A scoping review

10:50 to 12:20
Auditorium VII
Bianca Whiteside

Oral presentation

Drugs and climate change: knowledge gaps in monitoring environmental impacts of drugs

10:50 to 12:20
Room 1.08
Tim Surmont

Short communication

Enhancing Harm Reduction: A Qualitative Evaluation of Athens' Drug Consumption Room

10:50 to 12:20
Auditorium VII
Benjamin Scher

Oral presentation

European Hair Drug Analisys Network – A pioneer study to investigate the use of NPS and NSO

10:50 to 12:20
Room 5A
Elisa Fornero

Oral presentation

Fostering Community: A Mixed Method Analysis of Kosmicare's Mobile Drug Checking Service in Lisbon, Portugal

10:50 to 12:20
Room 5C
Helena Valente

Oral presentation

Health-related quality of life trajectories of patients in heroin-assisted treatment

10:50 to 12:20
Auditorium III
Francesca Melis

Oral presentation

Impact of long-acting depot buprenorphine post-release from custody– Early findings from the Release Study

10:50 to 12:20
Auditorium IV
Adrian Dunlop

Oral presentation

Key challenges for alcohol epidemiology and alcohol control policy evaluation

10:50 to 12:20
Auditorium VI
Jürgen Rehm

Oral presentation

Legally grey? Drug checking perspectives in the CEECA region

10:50 to 12:20
Auditorium VI
Eliza Kurcevič

Oral presentation

Opioid disorder treatment outcomes — the OPTIMUS international consensus on evidence-based and patient-centred care

10:50 to 12:20
Auditorium III
Lucas Wiessing

Short communication

Overdoses in the drug consumption room in Oslo: route of administration matters!

10:50 to 12:20
Auditorium VII
Desiree Eide

Oral presentation

Perceptions of family physicians in Istanbul on e-cigarettes as smoking cessation aids

10:50 to 12:20
Room 1.08
Melis Selamoglu

Oral presentation

Prevention of hazardous substance use among refugees – digital tools for the workforce in refugee aid

10:50 to 12:20
Room 5C
Jonathan Uricher

Oral presentation

Public health for whom? Unpacking the assumptions and silences in Canada's public health approach to substance use.

10:50 to 12:20
Auditorium VI
Sophie Henderson

Short communication

Reasons for (non-)using a drug consumption room: the point of view of drug users.

10:50 to 12:20
Auditorium VII
Sanda Samitca

Short communication

Safe Inhalation Pipe Provision Study: Intervening to improve policy and practice for people who use crack in England.

10:50 to 12:20
Auditorium VII
Magdalena Harris

Oral presentation

Synthesis of multisource data for the development of an advanced dashboard to monitor illicit drugs markets

10:50 to 12:20
Room 5A
Pierre Esseiva

Oral presentation

The Costs and Harms of Substance Use in Canada: Key Trends from 2007 to 2022

10:50 to 12:20
Auditorium VI
Pam Kent

Oral presentation

The situation of Harm Reduction in Spain: a qualititive approach incluying PWUD

10:50 to 12:20
Room 5C
Ester Aranda

Short communication

The Value of Peer Research: A Peer Perspective

10:50 to 12:20
Auditorium VII
Christos Anastasiou

Oral presentation

Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022

10:50 to 12:20
Auditorium III
Michael Farrell

Oral presentation

What can Portugal do to prevent be caught off guard again in the drug domain?

10:50 to 12:20
Room 5A
Alcina Correia

13:20

Short communication

Making a case for health promotion theoretically underpinned policies and practices around alcohol in workplace settings

13:20 to 14:50
Room 1.06
Lolita Alfred

Short communication

Introducing the European Prevention Curriculum (EUPC) in Austria – findings from a pilot implementation

13:20 to 14:50
Room 1.06
Martin Busch

Short communication

Advancing Science-Based Prevention: Insights from the EUPC Training in Bosnia and Herzegovina

13:20 to 14:50
Room 1.06
Amir Hasanovic

Short communication

Piloting EUPC Training in the Republic of Georgia: Lessons Learned

13:20 to 14:50
Room 1.06
Jana D. Javakhishvili

Short communication

TRAINING ON THE EUROPEAN PREVENTION CURRICULUM (EUPC) FOR DOPs- THE CYPRIOT EXPERIENCE

13:20 to 14:50
Room 1.06
Maria Matheou

Short communication

The Frontine Politeia project: the need for involving prevention implementers within substance use and crime prevention

13:20 to 14:50
Room 1.06
Annemie Coone

Oral presentation

Dynamic associations between anxiety and alcohol use from early adolescence to young adulthood.

13:20 to 14:50
Auditorium VII
Margot Peeters

Short communication

Strengthening the capacity and agency of drug prevention stakeholders on the key issue of evidence-based prevention.

13:20 to 14:50
Room 1.06
Rachele Donini

Oral presentation

A mixed methods systematic review of interventions for women in the perinatal period, who are dependent on drugs

13:20 to 14:50
Room 5B
Emma Smith

Short communication

A multisite implementation trial of collaborative care for Opioid Dependence: 3-month outcomes from the EPIC-MATOD trial

13:20 to 14:50
Room 1.05
Suzanne Nielsen

Oral presentation

A randomized controlled trial of support programs for parents of treatment-refusing substance using young adults

13:20 to 14:50
Auditorium VII
Ola Siljeholm

Short communication

A socio-ecological systematic review of harm reduction interventions addressing the U.S. opioid overdose epidemic

13:20 to 14:50
Room 1.05
Katie McCormick

Short communication

An economic evaluation of Catalonia’s Needle Exchange Programme (NEP). Cost-Benefit analysis

13:20 to 14:50
Room 1.05
Asier Narbarte Arzuaga

Oral presentation

Associations between opioid agonist therapy exposure and chronic pain characteristics among people who inject drugs

13:20 to 14:50
Auditorium IV
Sasha Udhesister

Oral presentation

Cannabis use disorder and the brain: The role of cross-cultural differences in cannabis attitudes

13:20 to 14:50
Auditorium III
Janna Cousijn

Oral presentation

Community-wide effects of building a resilient community healthcare workforce

13:20 to 14:50
Room 5C
Carol Jones

Oral presentation

Differential effects of left and right insula inhibition on craving and cognitive control in regular smokers

13:20 to 14:50
Auditorium III
Mieke Schulte

Oral presentation

Drug-related deaths among housed and homeless individuals in the UK and the USA

13:20 to 14:50
Auditorium IV
Emmert Roberts

Oral presentation

Drug-related mortality associated with gabapentinoid/Z-drug co-prescribing among opioid-agonist treatment recipients

13:20 to 14:50
Auditorium IV
Megan Glancy

Short communication

Effect of integrated smoking cessation treatment on smoking intensity among persons who receive opioid agonist treatment

13:20 to 14:50
Room 1.05
Karl Trygve Druckrey-Fiskaaen

Short communication

Empowering Global Drug Prevention: A Systematic Approach

13:20 to 14:50
Room 1.06
Ali Yassine

Oral presentation

EXPERIENCES OF DRUG CONSUMPTION ROOM PROFESSIONALS

13:20 to 14:50
Room 5C
Patricia Domingos Belo

Oral presentation

Female-specific trends and treatment needs for substance use disorder among homeless and at-risk females

13:20 to 14:50
Room 1.08
Anne Marie Carew

Oral presentation

Gender and drugs: Experiences of stigma/toxicophobia and narcofeminist narratives

13:20 to 14:50
Room 1.08
Marie Jauffret-Roustide

Oral presentation

High body mass index is prevalent in people with opioid use disorder in Northern England and increases risk of death

13:20 to 14:50
Auditorium IV
Caroline Copeland

Short communication

Homeless people and mental health: an observational study in an Emergency Shelter in Lisbon

13:20 to 14:50
Room 1.05
Gonçalo Henriques

Oral presentation

Innovation in caring for individuals experiencing polydrug use disorder: opportunities to understand multi-morbidities

13:20 to 14:50
Room 5C
Alexander Baldacchino

Short communication

Multi Parameter Estimation of Prevalence modelling: methods to estimate the prevalence of opioid dependence in Scotland

13:20 to 14:50
Room 1.05
Andreas Markoulidakis

Oral presentation

Peripheral endocannabinoids and related lipids in individuals with chronic non-medical prescription opioid use

13:20 to 14:50
Auditorium III
Sara Kroll

Oral presentation

Policy Responses to Drug-Related Deaths: The power of numbers?

13:20 to 14:50
Auditorium IV
Lena Eriksson

Oral presentation

Pregnancy-related hospitalisation among women who inject drugs in Melbourne, Australia

13:20 to 14:50
Room 5B
Ashleigh Stewart

Oral presentation

Substance use variation among LGBTQ+ youth: stress, resilience and ecosystemic intervention

13:20 to 14:50
Auditorium VII
Julie-Christine Cotton

Oral presentation

The care pathways of women who use drugs in the perinatal period. Findings of a qualitative, longitudinal study

13:20 to 14:50
Room 5B
Polly Radcliffe

Oral presentation

The genetic etiology of cannabis use: from twin models to genome-wide association studies and beyond

13:20 to 14:50
Auditorium III
Karin J. H. Verweij

Oral presentation

The perinatal period as a window of opportunity for change and recovery? A study of mothers and relatives' accounts

13:20 to 14:50
Room 5B
Sarah Vandewalle

Short communication

Treatment pathways and transitions of young adults during opioid maintenance treatment

13:20 to 14:50
Room 1.05
Sanna Iivonen

Oral presentation

Understanding substance use and affective symptoms in late adolescents in an urban context: A network approach

13:20 to 14:50
Auditorium VII
Helle Larsen

Oral presentation

Unveiling the Nexus of Addiction, Violence, and Risk: Generational Patterns in Female Populations

13:20 to 14:50
Room 1.08
Sabrina Molinaro

Oral presentation

Vulnerabilities and agencies of women who use and sell drugs in Bordeaux and Montréal

13:20 to 14:50
Room 1.08
Sarah Perrin

Oral presentation

What do clinicians think about psychedelic assisted therapy? An Australian perspective.

13:20 to 14:50
Room 5C
Zachary Bryant

15:00

Oral presentation

A comparative analysis of state-controlled models for legal cannabis sales in Uruguay and Quebec (Canada)

15:00 to 16:30
Auditorium VI
Marta Rychert

Oral presentation

A provisional evaluation of Australia’s medical cannabis framework

15:00 to 16:30
Auditorium VI
Myfanwy Graham

Oral presentation

Adverse childhood experiences and drug use in early adulthood: an analysis of the Growing Up in Ireland 1998 cohort

15:00 to 16:30
Room 5A
Deirdre Mongan

Oral presentation

Biography, age and temporality: understanding shifts in alcohol consumption over time among young abstainers

15:00 to 16:30
Room 5A
Amy Pennay

Oral presentation

Brorphine analogues as new psychoactive substances: in vitro and in vivo pharmacological characterization

15:00 to 16:30
Auditorium III
Marthe Vandeputte

Oral presentation

Consequences of cannabis legalization on use and health outcomes on the basis of international experiences

15:00 to 16:30
Auditorium VI
Uwe Verthein

Oral presentation

Factors associated with cocaine use in late adolescence and young adulthood in the Growing Up in Ireland cohort study

15:00 to 16:30
Room 5A
Margaret Brennan

Oral presentation

In vitro cannabinoid activity-based screening of seized plant materials: a future-proof harm reduction strategy?

15:00 to 16:30
Auditorium III
Axelle Timmermamn

Oral presentation

Neurotoxicity of synthetic cathinones: Can metabolism play a role?

15:00 to 16:30
Auditorium III
Alexandra Antunes

Oral presentation

Online Addictions Expert Group of the Pompidou Group: Results and Recommendations

15:00 to 16:30
Room 5B
Jann Schumacher

Oral presentation

Pharmacology of 30 semisynthetic cannabinoids – and why details matter when assessing the harm potential of seized drugs

15:00 to 16:30
Auditorium III
Christophe Stove

Oral presentation

Prevention when exclusion is lifted: Intervention models from the New Swiss Gambling Act

15:00 to 16:30
Room 5B
Linda Elezi

Oral presentation

Risks and harms associated with online gaming and gambling

15:00 to 16:30
Room 5B
Eduarda Ferreira

Oral presentation

Same Intentions, Different Outcomes: Divergent Paths and Implementation Gaps in Cannabis Legalization in North America

15:00 to 16:30
Auditorium VI
Ivana Obradovic

Oral presentation

The end of responsible gambling

15:00 to 16:30
Room 5B
Charles Livingstone

Oral presentation

Who is driving under the influence of cannabis in Germany? Findings of a large-scale online survey

15:00 to 16:30
Room 5A
Anna Schranz

16:50

Oral presentation

Epidemiology of injecting drug use and injection related harms among people who are incarcerated

16:50 to 18:20
Auditorium IV
Louisa Degenhardt

Short communication

A comparison of sales regulations across three types of cannabis dispensaries: First insights from the 'Züri Can' study

16:50 to 18:20
Room 1.06
Nadine Heckel

Oral presentation

Cocaine use on the rise – are politicians and city level services prepared for the emerging trend of crack cocaine?

16:50 to 18:20
Auditorium III
Else Kristin Utne Berg

Oral presentation

Context specific factors that impact on the optimal scale up of hepatitis C testing and treatment in the UK

16:50 to 18:20
Auditorium IV
Peter McCulloch

Short communication

Designing an online training course for professionals dealing with pornography use and sexual dysfunctions

16:50 to 18:20
Room 1.07
Mary Sharpe

Oral presentation

Dual diagnosis and their care pathways for help-seeking: a multi-center study from India

16:50 to 18:20
Auditorium VII
Abhishek Ghosh

Short communication

Exploring exposure to drug-related content on social media among youth and a pilot of drug prevention on TikTok

16:50 to 18:20
Room 1.07
Martha de Jonge

Short communication

Happy, healthy smartphone use: A participatory action research to improve higher education students’ mental well-being

16:50 to 18:20
Room 1.07
Madelief Harten

Oral presentation

Impact of mental health on retention in OAT

16:50 to 18:20
Auditorium VII
Lucy Thi Tran

Oral presentation

Intervention development of a nature-based programme for co-occurring mental health and substance use problems.

16:50 to 18:20
Auditorium VII
Wendy Masterton

Short communication

Is attentional absorption a risk factor for smartphone addiction?

16:50 to 18:20
Room 1.07
Rui Miguel Costa

Oral presentation

Islands in the stream: The accessibility of mental health care for persons with substance use problems in Belgium

16:50 to 18:20
Auditorium VII
Clara De Ruysscher

Oral presentation

It is time to take nitrous oxide seriously

16:50 to 18:20
Room 5C
Julaine Allan

Short communication

Loneliness in the Digital Age:Role of Loneliness in Online Self-Verification and Social Media Addiction in Six Countries

16:50 to 18:20
Room 1.07
Iina Savolainen

Short communication

Managing the drug-driver: insights from Victoria’s large-scale roadside testing program

16:50 to 18:20
Room 1.06
Michael Fitzharris

Short communication

Metabolite profile of synthetic cannabinoids seized in Portugal

16:50 to 18:20
Room 1.06
Rita Padinha Lopes

Oral presentation

Misuse of psychoactive medicines and its harmful consequences in Portugal

16:50 to 18:20
Auditorium VIII
Ana Araújo

Oral presentation

Nangs in Australia: Investigating nitrous oxide use among people who regularly use MDMA and/or other illicit stimulants

16:50 to 18:20
Room 5C
Jodie Grigg

Oral presentation

New challenges for outpatient care: trends from twenty years of monitoring treatment demand in the city of Hamburg

16:50 to 18:20
Room 5C
Marcus Martens

Oral presentation

Population aging and apparent decline in initiation of injecting drug use in Australia

16:50 to 18:20
Room 5C
Olivia Price

Short communication

Presentation of a National Observatory for Internet and Gaming Addiction in Greece

16:50 to 18:20
Room 1.07
Georgios Floros

Short communication

Procrastination and Problematic Social Network Sites Use in adolescents: a serial mediation model

16:50 to 18:20
Room 1.07
Sara Bocci Benucci

Short communication

Project on fine default prisoners with substance abuse problems – preliminary findings of an evaluation and impact study

16:50 to 18:20
Room 1.06
Jukka Leinonen

Short communication

Recommendations from the government cannabis committee on the legal availability of vaping products.

16:50 to 18:20
Room 1.06
Robert Perreault

Oral presentation

Responding to the identification of nitazenes within the illicit diazepam market

16:50 to 18:20
Auditorium III
Josie Smith

Short communication

Risk factors for the social networking sites addiction: a systematic review

16:50 to 18:20
Room 1.07
Susanna Puigcorbé

Oral presentation

Socioeconomic risk factors for long-term prescription opioid use: A national registry-linkage study

16:50 to 18:20
Auditorium VIII
Ingvild Odsbu

Oral presentation

The development of a toolkit to support the elimination of viral hepatitis B and C in prisons

16:50 to 18:20
Auditorium IV
Erika Duffell

Short communication

The experience of aging among patients in opioid assisted treatment. A qualitative study.

16:50 to 18:20
Room 1.06
Siv-Elin Leirvåg Carlsen

Short communication

The impact of Cannabis market Regulation on adolescents in Uruguay

16:50 to 18:20
Room 1.06
Leticia Keuroglian

Oral presentation

Towards elimination of hepatitis C in Oslo: cross-sectional prevalence studies in 2018, 2021, 2022 and 2023

16:50 to 18:20
Auditorium IV
Eirik Opheim

Oral presentation

Understanding Drug Use in a Dutch Prison: A Call for Improved Research and Care and Lessons learned

16:50 to 18:20
Auditorium III
Daan van der Gouwe

Oral presentation

Using intensive longitudinal data to investigate predictors of cannabis and opioid use among patients with chronic pain

16:50 to 18:20
Auditorium VIII
Johannes Thrul

Oral presentation

Words vs. strands: Does the concordance of self-reported and hair-analyzed substance use of young adults change over time?

16:50 to 18:20
Auditorium III
Clarissa Janousch
Fri 25 Oct

10:50

Oral presentation

Situation in Afghanistan: Opium cultivation and heroin production

10:50 to 12:20
Auditorium I
Angela Me

Oral presentation

Substance use patterns among young homicide offenders in Finland 2002-2022

10:50 to 12:20
Auditorium VIII
Anna Raeste

Oral presentation

Homicides committed by criminal groups involved in Swedish drug distribution

10:50 to 12:20
Auditorium VIII
Kim Moeller

Oral presentation

Opium and heroin production in Southeast Asia

10:50 to 12:20
Auditorium I
Bryce Pardo

Oral presentation

An exploration of drug market, gun violence and sociodemographic patterns in Stockholm Sweden and the prediction of gun violence

10:50 to 12:20
Auditorium VIII
Mia-Maria Magnusson

Oral presentation

Implications of heroin shortages in Europe: the emergence of synthetic opioids

10:50 to 12:20
Auditorium I
Joanna Morais

Oral presentation

Revisiting Goldstein: A New Framework for Understanding Drug-Related Violence in a Globalised Era

10:50 to 12:20
Auditorium VIII
Marieke Liem

Oral presentation

The evolving situation with nitazenes in Ireland

10:50 to 12:20
Auditorium I
Eamon Keenan

Short communication

#What´sUP_TuDecides – Healthy Influencer of Internet and Gaming Use

10:50 to 12:20
Room 1.06
Carla Andrade

Oral presentation

Accidental versus intentional drug overdose deaths: a national register linkage study

10:50 to 12:20
Auditorium IV
Rebecca McDonald

Short communication

An action plan for synthetic opioids - The Zurich approach

10:50 to 12:20
Room 1.05
Dominique Schori

Oral presentation

An online survey of cannabis users and ex-users in Ireland

10:50 to 12:20
Room 5B
Philip James

Oral presentation

Behind the frontlines: Exploring mental well-being and burnout among harm reduction workers

10:50 to 12:20
Room 1.07
Katie McCormick

Short communication

Community attitudes towards sanction and health-based interventions for individuals caught drug-driving in Australia

10:50 to 12:20
Room 1.05
Sara Liu

Oral presentation

Current perspectives on the research and medical use of psychedelic drugs for alcohol addiction treatment

10:50 to 12:20
Auditorium VI
Anton Gomez-Escolar

Oral presentation

Development and validation of the Problematic Dating App Use Scale (PRODAS): First results from a sexual minority cohort

10:50 to 12:20
Auditorium III
Babette Lea Winter

Short communication

Development of an evidence-based classification framework for psychoactive substances in the illicit drug market

10:50 to 12:20
Room 1.05
Michèle Boileau-Falardeau

Oral presentation

Do Self-Report Drug Use Surveys Produce the Same Results in Print and Online Mode? Findings from a Dual Mode Survey.

10:50 to 12:20
Room 5B
Stelios Stylianou

Oral presentation

Drug use in French prisons. Results of the ESSPRI survey

10:50 to 12:20
Room 5C
Caroline Protais

Oral presentation

Drug-induced deaths and non-fatal poisonings in youth – associations with ACE and psychiatric morbidity

10:50 to 12:20
Auditorium IV
Karoliina Karjalainen

Short communication

Exploring characteristics of videogame use and mental health in expert and casual female gamers

10:50 to 12:20
Room 1.06
Roxanne Hébert-Ratté

Short communication

Gabapentinoids in Ireland (2010-2020): trends in prescribing, law enforcement drug seizures & post-mortem toxicology

10:50 to 12:20
Room 1.05
Gráinne Cousins

Oral presentation

Illegal loot box advertising on social media: an empirical study using the Meta and TikTok ad transparency repositories

10:50 to 12:20
Auditorium III
Leon Y. Xiao

Short communication

Increasing availability and production of synthetic cathinones in Europe – a perspective from the EU EWS

10:50 to 12:20
Room 1.05
Gregorio Planchuelo

Short communication

MDMA misinformation: what dealers claim versus the actual MDMA content in ecstasy pills in the netherlands

10:50 to 12:20
Room 1.05
Lavinia Stegemann

Short communication

Media portrayal of sports betting in Canada before and after Bill C-218

10:50 to 12:20
Room 1.06
Luke Clark

Short communication

New research unit provides evidence to address national addictions policy challenges

10:50 to 12:20
Room 1.05
Leonie Brose

Oral presentation

Online approach and characteristics of the hidden population with substance use disorder that doesn’t reach treatment

10:50 to 12:20
Room 5B
Ilias Paraskevopoulos

Oral presentation

Overdoses in Healthcare Workers: A thematic framework analysis of coroner reports

10:50 to 12:20
Room 1.07
Thikra Algahtani

Oral presentation

Predictors of untreated remission of Internet Use Disorder in a sample of adolescents and young adults

10:50 to 12:20
Auditorium III
Lasse Schmidt

Oral presentation

Prevalence of Benzodiazepine Prescription Prior to Overdose Deaths Compared to Toxicological Findings

10:50 to 12:20
Auditorium IV
Anna Armika Tussilago Nyman

Oral presentation

Prison-based treatment needs for people with a history of substance use disorder: A nationwide cohort study

10:50 to 12:20
Room 5C
Birgitte Thylstrup

Oral presentation

Psychedelic therapy in the treatment of addiction: the past, present and future

10:50 to 12:20
Auditorium VI
Rayyan Zafar

Oral presentation

Relationship between parenting styles and problematic Internet use

10:50 to 12:20
Auditorium III
Antonio Raya

Short communication

Sex differences in gaming disorder: Implication for a comprehensive treatment in lower-middle income country

10:50 to 12:20
Room 1.06
Kristiana Siste

Oral presentation

Substance use and psychological states in imprisoned population in Greece—Key findings from a recent nationwide survey

10:50 to 12:20
Room 5C
Ioulia Bafi

Oral presentation

Suicide in people prescribed opioid-agonist therapy (OAT) in Scotland, 2011-2020: a national retrospective cohort study.

10:50 to 12:20
Auditorium IV
Rosalyn Fraser

Short communication

The comparison of gaming and gambling in relation to decision-making behavior and implicit associations

10:50 to 12:20
Room 1.06
Nanne Dominick

Short communication

The emergence of nitazenes on the Irish heroin market: Lessons learned and challenges moving forward

10:50 to 12:20
Room 1.05
Nicki Killeen

Short communication

The Football Fans and Betting Project – Findings from an early intervention for male sports bettors

10:50 to 12:20
Room 1.06
Blair Biggar

Oral presentation

The Mental Health Challenges Faced by Harm Reduction Staff

10:50 to 12:20
Room 1.07
Laoise Darragh

Oral presentation

The old kid in the block: Unpacking signals of increased availability and use of ketamine

10:50 to 12:20
Auditorium VI
Rita Jorge

Oral presentation

The Pharmacological Management of Ketamine Use Disorder: A Systematic Review

10:50 to 12:20
Auditorium VI
Emmert Roberts

Discussion

The ripple effect: International developments in the opioid market and their potential implications for European public health and security

10:50 to 12:20
Auditorium I
Steve Taylor

Oral presentation

Vicarious Trauma Among Nurses Working in Addiction Services and the Role of Leadership: A European Mixed Methods Study

10:50 to 12:20
Room 1.07
K. Nicki Annunziata

Short communication

Video gaming in older adults: Resilience to impairment

10:50 to 12:20
Room 1.06
Daniel Stjepanovic

Short communication

Video gaming: observational, genetic, and causal associations with cognition and health

10:50 to 12:20
Room 1.06
Joelle Pasman

Oral presentation

What can we learn about poly-drug use among frequent cannabis users? results from the European Web Survey on Drugs

10:50 to 12:20
Room 5B
Davide Fortin

13:20

Oral presentation

Update on the situation in the Netherlands (tbc)

13:20 to 14:50
Auditorium VIII
Margriet Van Laar

Oral presentation

Work related cocaine use: prevalence and interventions

13:20 to 14:50
Auditorium II
Marie-Claire Lambrechts

Oral presentation

Cannabis law reform in Switzerland: purpose, opportunities, and risks of local pilot projects

13:20 to 14:50
Auditorium VIII
Frank Zobel

Oral presentation

Issues of transport, driving safety & intoxication for opioid agonist treatment clients in New South Wales, Australia

13:20 to 14:50
Auditorium VI
Daniel Winter

Oral presentation

The Workplace as a “Co-Therapist”

13:20 to 14:50
Auditorium II
Camilla Lynne Bakkeng

Oral presentation

Cannabis law reform in Germany: a rocky road to a partial legalisation

13:20 to 14:50
Auditorium VIII
Jakob Manthey

Oral presentation

Individual agreements for recovery from substance misuse. Employees’ response and experience of regulatory aspects.

13:20 to 14:50
Auditorium II
Marianne Lund

Oral presentation

Physical conditions and associated health service utilization among individuals with substance-related disorders

13:20 to 14:50
Auditorium VI
Christophe Huỳnh

Oral presentation

A healthy work environment for Eastern European migrant workers in The Netherlands

13:20 to 14:50
Auditorium II
Desirée Spronk

Oral presentation

Cannabis law reform in Luxembourg: first observations after its change among recreational cannabis users and non-users

13:20 to 14:50
Auditorium VIII
Nadine Berndt

Oral presentation

The effect of substance use disorders on vaccine uptake, acceptance, and adherence: a global systematic review

13:20 to 14:50
Auditorium VI
Eva Maria Havelka

Oral presentation

Out of treatment drug and alcohol users in England: ‘Unmet Treatment Need’?

13:20 to 14:50
Auditorium VI
Charlie Lloyd

Oral presentation

Pathways into individual substance misuse recovery agreement in the workplace

13:20 to 14:50
Auditorium II
Janne Scheffels

Oral presentation

Addressing Alcohol-Related Risks among Individuals with Disabilities in Sports: A Swiss Perspective

13:20 to 14:50
Room 5A
Nikolai Kiselev

Oral presentation

Are Take-Home Naloxone kits available at witnessed overdose events - a European Naloxone Outcome Research Study

13:20 to 14:50
Auditorium IV
Teodora Dascal

Oral presentation

Culturally safe addiction services: An integrated circle of care for homeless Indigenous peoples in Montréal, Canada

13:20 to 14:50
Room 5A
Jessica Neicun

Oral presentation

Development, implementation and liquidation of a national Danish Train-the-Trainer system 2010 - 2023

13:20 to 14:50
Auditorium IV
Henrik Thiesen

Oral presentation

Evaluating a pilot intervention development programme utilising respiratory monitoring to prevent drug-related deaths

13:20 to 14:50
Auditorium IV
Kristina Hnízdilová

Oral presentation

Impact of Precursor Control on Drug Markets: An Expanded and Updated Systematic Review

13:20 to 14:50
Room 5B
Luca Giommoni

Oral presentation

Interventions to reduce harms related to drug use among people who experience incarceration: A systematic review

13:20 to 14:50
Auditorium VII
Christel Macdonald

Oral presentation

PRS20: drug use and perceived mental health concerns among people living in prison in the Grand-Duchy of Luxembourg

13:20 to 14:50
Auditorium VII
Tom Kugener

Oral presentation

Radio theater-based prison artistic intervention: a mixed-method evaluation

13:20 to 14:50
Auditorium VII
Isabel Silva

Oral presentation

Spatial analysis of drug seizure events in the Golden Triangle: Findings from UNODC’s Drug Monitoring Platform

13:20 to 14:50
Room 5B
Bryce Pardo

Oral presentation

Substance Use, Well-being, and Spiking among LGBTIQ+ and Non-LGBTIQ+ Nightlife Patrons: A Cross-Sectional Survey

13:20 to 14:50
Room 5A
Ruben van Beek

Oral presentation

The impact of the 2022 ban on drug production in Afghanistan

13:20 to 14:50
Room 5B
Angela Me

Oral presentation

The impacts of cannabis legalization in the Americas: Insights from a systematic review

13:20 to 14:50
Room 5B
Elle Wadsworth

Oral presentation

The multidimensional needs and integrated service utilization patterns of youth using non-medical prescription opioids

13:20 to 14:50
Room 5A
Kirsten Marchand

Oral presentation

Who reports witnessing an opioid overdose? : Findings from the European naloxone outcome research study (NalPORS)

13:20 to 14:50
Auditorium IV
Clare Mackie